July 2016

D R K I M L . L A V O I E , P H D P R O F E S S O R , R E S E A R C H E R , C L I N I C A L H E A L T H P S Y C H O L O G I S T

ADDRESS FOR CORRESPONDENCE:

Department of Psychology, University of Quebec at Montreal (UQAM) CP 8888, Succursale Centre, Ville Montreal, Quebec, H3C 3P8 Tel: 514-987-3000 (ext 3835) Fax: 514-987-7953 email: kiml_lavoie@yahoo.ca Website: www.mbmc-cmcm.ca Citizenship: Canadian Languages: English and French

ACCREDITATIONS AND LISCENCES: Canadian Register of Health Service Providers (2005 – present) Order of Psychologists of Quebec (#0875-25) (1999 – present) POSITIONS HELD: Institute Department Dates Position UQAM Psychology 06/2014-pres Full Professor Hôpital du Sacré-Cœur de Montréal Chronic Disease Division 6/2012-pres Director Concordia University Exercise Science 8/2011-pres Affiliate Professor University of Montreal Medicine 07/2009-pres Associate Professor Montreal Behavioural Medicine Centre Research Center 06/2005-pres Co-Director Montréal Heart Institute Research Center 06/2005 Associate Researcher Hôpital du Sacré-Cœur de Montréal Research Center 06/2002 Full Researcher UQAM Psychology 06/2009-2014 Associated Professor UQAM Psychology 06/2005-2009 Assistant Professor EDUCATION: Institute Degree Dates School / Department University of Pittsburgh, USA Certificate 06/2010 Mind-Body Center, Psychology McGill University, CANADA Postdoc 6/02 – 6/05 Psychology Hôpital du Sacré-Cœur, CANADA Postdoc 6/02 – 6/05 Pneumology; Axe de recherche en santé

respiratoire University of Pittsburgh, USA Certificate 06/2004 Mind-Body Center, Psychology University of Pittsburgh, USA Certificate 06/2003 Mind-Body Center, Psychology Duke University Medical Center, USA Certificate 05/2003 Psychiatry & Behavioral Sciences Columbia University, USA Certificate 11/2002 Psychiatry Concordia University, CANADA PhD 09/97-05/03 Psychology Concordia University, CANADA MA 09/95-09/97 Psychology McGill University, CANADA BA (hons) 09/92-09/95 Psychology John Abbott College, CANADA DEC 09-90-09/92 Commerce

Kim L. Lavoie Ph.D.

V June 2016

RESEARCH INTERESTS: In general, my research interests fall into 3 categories: the impact of psychological stress (e.g., depression, anxiety) and lifestyle factors (diet, exercise, smoking, adherence) on the development and progression of chronic disease (e.g., cardiovascular disease, asthma, COPD, and obesity); psychophysiological and behavioral mechanisms linking psychological stress to disease; and behavioural medicine (e.g., behavioral interventions for chronic disease primary, secondary and tertirary prevention including motivational communication/counselling and cognitive-behavioral approaches). RESEARCH PRODUCTIVITY: SUMMARY Grants

(principle investigator) Grants

(co-investigator) Total $3,748,192 $14,024,344

RESEARCH FUNDING: A. Funds requested (2015-2016): Source: Canadian Initiative for Outcomes in Rheumatology Care (CIORA) Title: Development and usability testing of the OA Go Away mobile application Duration: 2 yrs Amount: $ 120,000 Role: Co-investigator (Co-I) Source: Canadian Institutes of Health Research (CIHR) Title: Targeting health behaviour and lifestyle change for the prevention of chronic disease: towards the

integration of evidence-based behavioural medicine into mainstream practice Duration: 7 yrs Amount: $ 2,100,000 Role: Named Program Expert Source: Canadian Institutes of Health Research (CIHR) Title: A motivational intervention to improve adherence to dyslipidemia medication Duration: 3 yrs Amount: $ 299,794 Role: Co-PI Source: Canadian Institutes of Health Research (CIHR) Title: Behavioral weight loss for asthma Trial (BEAT) Duration: 3 yrs Amount: $ 700,000 Role: Co-PI Source: Canadian Institutes of Health Research (CIHR) Title: Smoking and stress reactivity: comparison of traditional and e-cigarettes on stress reactivity

responses Duration: 3 yrs Amount: $ 600,000 Role: PI

Kim L. Lavoie Ph.D.

V June 2016

B.1 Grants awarded as PI or Co-PI: Source: Canadian Initiative for Outcomes in Rheumatology Care (CIORA) Title: Strategies to enhance Influenza/Pneumococcal vaccination uptake among rheumatoid arthritis

patients Duration: July 2016-July 2018 Amount: $ 120,000 Role: Co-PI Source: Canadian Institutes of Health Research (CIHR) Title: Optimizing physician training in motivational interviewing (MI) to improve MC competency, patient

health behaviors, and morbidity among patients with cardiovascular and chronic lung disease Duration: 1/10/14-30/09/19 Amount: $ 683,685 Source: Concordia University: Horizon Postdoctoral Fellowships Competition (for supervisors) Title: Optimizing physician training in motivational communication (MC) skills for health behavior change Duration: Jan 2017-Jan 2019 Amount: $ 100,000 Role: Co-PI Source: Fonds de la recherché du Quebec-Sante (Reseau Sante Respiratoire) Title: RESP Asthma-COPD Cohort Study Duration: 12/15-12/15 Amount: $ 20,000 Role: Co-PI Source: Canadian Institutes of Health Research (CIHR) Title: The Canadian Airway Disease Research Network (CARN) – SPOR LOI Duration: 01/15-01-16 Amount: $ 50,000 Role: Co-PI Source: Centre de recherche/Fondation de l’Hopital du Sacre-Coeur de Montreal Title: Bariatric care cohort study Duration: 12/14-12/15 Amount: $ 60,000 Source: Abbvie Inc. Title: Physician training in motivational communication skills: The impact of Derm Connect Canada Duration: 08/14-08/16 Amount: $ 60,386 Source: Canadian Institutes of Health Research (CIHR) Title: Optimizing physician training in motivational interviewing (MI) to improve MI competency, patient

health behaviors, and morbidity among patients with cardiovascular and chronic lung disease Duration: 04/2014-04/2015 Amount: $100,000 Source: Canadian Institutes of Health Research (CIHR) – Planning Grant Title: International Behavioural Trials Network Duration: 2014/01 – 2015/01 Amount: $25,000 Role: Co-PI Source: Fondation de l’Hopital du Sacre-Coeur de Montreal Title: The impact impact of acute stress in asthmatics with and without depression Duration: 2013/09-2015/09 Amount: $22,000 Source: Canadian Institutes of Health Research (CIHR): New Investigator Award Title: The impact of a brief motivational intervention on adherence behavior in

asthmatics: A randomized controlled trial Duration: 2012/09-2017/08 Amount: $300,000 Source: Fonds de la recherche en santé du Quebec (FRSQ)-Chercheur Boursier Junior 2 Title: Le rôle des facteurs psychologiques et comportmentales sur les maladies chroniques Duration: 2011/04-2015/04 Amount: $309,891

Kim L. Lavoie Ph.D.

V June 2016

Source: Canadian Institutes of Health Research (CIHR) Title: The impact of motivational interviewing on adherence to inhaled corticosteroids and asthma

control in poorly controlled, non-adherent asthmatics Duration: 2011/04-2015 Amount: $448,000 Source: Canadian Institutes of Health Research (CIHR) Title: Predictors of differential cardiovascular morbidity and mortality in older men and women: A

prospective study. Duration: 2008-2013 Amount: $383,559 Source: Social Sciences and Humanities Research Council (SSHRC) Title: Impact of mood and anxiety disorders on asthma control and quality of life Duration: 07/08-07/11 Amount: $164,590 Source: Heart & Stroke Foundation of Canada -Quebec Title: CAD risk associated with clinical vs. sub-clinical depression Duration: 06/07-06/10 Amount: $80,000 Source: Fonds de la Recherche en Santé du Québec (FRSQ)- Établissement des jeunes chercheurs Title: Impact du stress psychologique sur l’asthme Duration: 06/06-06/10 Amount: $30,000 Source: Fonds de la Recherche en Santé du Québec (FRSQ)- Chercheur-Boursier Clinicienne Award Title: Impact du stress psychologique sur l’asthme Duration: 06/06-06/10 Amount: $160,000 Source: Glaxo-Smithkline (GSK) – Investigator-initiated grants program Title: The development of a brief motivational intervention to improve adherence behaviours in asthma Duration: 09/07-09/09 Amount: $184,044 Source: Canadian Institutes of Health Research (CIHR) - Pilot Project Title: The interaction of work stress and sex on the prediction of occupational asthma Duration: 06/07-06/08 Amount: $20,000 Source: University of Quebec at Montreal (UQAM) Title: Psychophysiological assessment of stress – equipment grant Duration: 06/07 Amount: $10,000 Source: Institut de Recherche en Santé en Sécurité au Travail (IRSST) Title: Prevalence and impact of psychosocial factors on 12 month prognosis of patients referred for

evaluation of occupational asthma Duration: 05/06-05/09 Amount: $181,190 Source: Canadian Institutes of Health Research (CIHR) - Pilot Project Title: Does chronic psychological stress enhance autonomic and immune responses to specific antigen

challenge in patients with occupational asthma? Duration: 06/06-06/07 Amount: $20,000 Source: Canadian Institutes of Health Research (CIHR) - Pilot Project Title: Psychological profile and hyperventilation syndrome in patients with occupational asthma and asthma

exacerbated by the workplace Duration: 06/04-06/05 Amount: $20,000

Kim L. Lavoie Ph.D.

V June 2016

Source: Fondation de l’Hôpital du Sacré-Cœur de Montréal Title: Bronchial Responsiveness to Methacholine and Carbon Dioxide Challenges in Asthma Patients with

and without Panic Disorder Duration: 10/02-10/04 Amount : $50,000 Source: Canadian Institutes of Health Research (CIHR) - Pilot Project Title: Bronchial, inflammatory, and autonomic responses to acute psychological stress in patients with

occupational asthma. Duration: 06/05-06/06 Amount: $20,000 Source: Research Centre, Hopital du Sacre-Coeur de Montreal Title: Stress and asthma research program (start-up funds) Duration: 2003 Amount: $15,000 B.2 Grants awarded as a co-investigator: Source: Public Health Ontario, Project Initiation Fund Title: Hand Hygiene Behaviour Change (HHBC) Tool: A Tool for Hand Hygiene Intervention Development Duration: Jan 2016-Jan 2017 Amount: $ 61,145 PI = Gary Garber, MD Source: Canadian Partnership Against Cancer – Coalitions Linking Action and Science for Prevention 2 Title: ACtivity, smoking Cessation, healthy Eating and aLcohol intERvention & motivATION

(ACCELERATION) Program Duration: 2013/01 – 2017/01 Amount: $2,400,000 PI = Paul Oh, MD Source: Networks of Centres of Excellence (NCE) – Planning Grant Title: MatriNET - Matrix and Tissue Remodeling Network Duration: 2014/01 – 2015/01 Amount: $25,000 PI = Ian Dixon, PhD Source: Canadian Institutes of Health Research (CIHR) Title: Mechanisms of elevated blood clotting during acute psychological stress Duration: 2013/07-2017/08 Amount: $297,000 PI = Simon Bacon, PhD

Source: Canadian Institutes of Health Research (CIHR) Title: Asthma during pregnancy and the health of the mother Duration: 2013/04-2017/04 Amount: $385,000 PI = Lucie Blais, PhD Source: Canadian Institutes of Health Research (CIHR) – Café Scientifique Title: How do we manage chronic disease as we age? Duration: 2013/10-2016/10 Amount: $3,000 PI = Stacey Grocholski Source: The Auger Foundation (Hopital du Sacre-Coeur de Montreal) Title: Base de données - Respiratoire (BD-RESP) study Duration: 2012/12-2014/12 Amount: $50,000 PI = Lucie Blais, PhD Source: Canadian Institutes of Health Research (CIHR) Title: Optimization of pulmonary rehabilitation programmes: the OPTION study Duration: 2012/04-2013/04 Amount: $100,000 PI = Veronique Pepin, PhD Source: C anadian Institutes of Health Research (CIHR) Title: Maximizing the effects of self-management interventions on chronic disease outcomes: The

development of a Chronic Obstructive Pulmonary Disease (COPD) web-based patient portal

Kim L. Lavoie Ph.D.

V June 2016

Duration: 2011/07-2014/07 Amount: $320,000 PI = Sarah Ahmed, PhD & Jean Bourbeau, MD Source: Canadian Institutes of Health Research (CIHR) Title: Exploring barriers to optimal asthma management by physicians Duration: 2011/06-2012/06 Amount: $200,000 PI = F. Ducharme, MD Source: Canadian Institutes of Health Research (CIHR) Title: Canadian Cohort Obstructive Lung Disease (CanCOLD) Duration: 2011/06-2017/06 Amount: $2,000,000 PI = J. Bourbeau, MD Source: Heart and Stroke Foundation of Canada Title: “GENESIS PRAXY: GENdEr and Sex DetermInantS of Cardiovascular Disease: From Bench to Beyond PRemature Acute Coronary Syndrome” Duration: 2011-14 Amount: $528,524.00 PI = Louise Pilote, MD Source: Canadian Institutes of Health Research (CIHR) Title: “GENESIS PRAXY: GENdEr and Sex DetermInantS of Cardiovascular Disease: From Bench to Beyond PRemature Acute Coronary Syndrome” Duration: 2011-12 Amount: $100,000.00 PI = Louise Pilote, MD Source: Canadian Institutes of Health Research (CIHR) Title: Quebec Respiratory Health Training Program Duration: 2009-2016 Amount: $1,900,000 PI = Francois Maltais, MD Source: Fonds de la recherche en santé du Québec (FRSQ) Title: La prise en charge de la dépression chez les adultes atteints de maladies physiques chroniques Duration: 2009-2012 Amount: $800,000 PI=Jane McCusker, MD/PhD Source: Canadian Institutes of Health Research (CIHR) Title: Aerobic exercise as an intervention for asthma morbidity in adults Duration: 2009-2012 Amount: $322,000 PI = Simon Bacon, PhD Source: Canadian Institutes of Health Research (CIHR) Title: Predictors of cardiovascular morbidity and mortality in women: a new independent non-invasive

procedure for risk stratification Duration: 06/06-06/11 Amount: $461,490 PI = Dr. Simon Bacon Source: Heart and Stroke Foundation of Canada Title: PRAXY Duration: 07/08-07/10 Amount: $620,000 PI = Louise Pilote, MD Source: Canadian Institutes of Health Research (CIHR) Title: PRAXY Duration: 07/09-07/10 Amount: $100,000 PI = Louise Pilote, MD Source: Glaxo-Smithkline (GSK) – Investigator-initiated grants program Title: Intervention by Community Pharmacists to Increase Adherence to Maintenance Medication for the

Treatment of Asthma Duration: 07/08-07/10 Amount: $168,000 PI = Manon Labrecque, MD Source: Fonds de la recherche en santé du Québec (FRSQ) Title: Optimisation d'un programme de réadaptation respiratoire Duration: 06/07-06/10 Amount: $244,589 PI = Veronique Pépin, PhD

Kim L. Lavoie Ph.D.

V June 2016

Source: Canadian Institutes of Health Research-Asthma in the Workplace Center Title: The impact of depression and anxiety on occupational asthma outcomes and inflammatory markers Duration: 06/08-06/09 Amount: $20,000 PI = Manon Labrecque, MD Source: Canadian Institutes of Health Research (CIHR) Title: Évaluation de l’efficacité de traitements du trouble panique chez des individus consultant à

l’urgence pour des douleurs thoraciques à faible risque de problème cardiaque Duration: 07/06-07/09 Amount: $350,000 PI = Andre Marchand, PhD Source: Canadian Institutes of Health Research-Asthma in the Workplace Center Title: The impact of daily psychological stress at work on occupational asthma Duration: 06/08-06/09 Amount: $20,000 PI = Simon Bacon, PhD Source: Canadian Institutes of Health Research-Institute of Cardiovascular and Respiratory Health (CIHR-IRSC) Title: New Frontiers Program: Behavioural, Psychological, Social and Environmental Factors Important in the

Primary and Secondary Prevention of Cardiovascular, Cerebrovascular and Respiratory Diseases Duration: 01/08-08/08 Amount: $75,000 PI = Judy Guernsey, PhD Source: Canadian/Quebec Lung Association Title: Optimisation d'un programme de réadaptation respiratoire : projet pilote Duration: 06/07-06/09 Amount: $20,000 PI = Veronique Pépin, PhD

Source: Canadian Institutes of Health Research (CIHR) Title: Occupational Asthma (Equipment grant) Duration: 06/06-06/07 Amount: $149,421 PI = Dr. Jean-Luc Malo Source: Canadian Institutes of Health Research (CIHR) - Pilot Project Title: Exposure characteristics in vocational schools in carpentry, plastering and plumbing and relationship

with exacerbation of asthma at work. Duration: 06/06-06/07 Amount: $20,000 PI = Dr. Denyse Gautrin Source: Canadian Institutes of Health Research (CIHR) - Pilot Project Title: Long-term assessment of Reactive Airways Dysfunction Syndrome Duration: 06/06-06/07 Amount: $20,000 PI = Dr. Jean-Luc Malo Source: Canadian Institutes of Health Research (CIHR) Title: Asthma in the Workplace Research Center Duration: 06/03-06/08 Amount: $2,100,000 PI = Dr. Jean-Luc Malo

Source: Fondation de l’Hôpital du Sacré-Cœur de Montréal Title : État psychologique en période stable chez les patients souffrant d’une MPOC: influence sur le

pronostic psychologique, médical et le taux de réexacerbation Duration: 03/03-03/06 Amount: $104,175 PI = Dr. Manon Labrecque Source: Canadian Institutes of Health Research (CIHR) - Pilot Project Title: Asthma exacerbated by the workplace in construction-worker apprentices Duration: 06/04-06/05 Amount: $20,000 PI= Dr. Denyse Gautrin Source: Canadian Institutes of Health Research (CIHR) - Pilot Project Title: Towards a better understanding of asthma exacerbated by the workplace: a pilot study Duration: 06/04-06/05 Amount: $20,000 PI = Dr. Catherine Lemière

Kim L. Lavoie Ph.D.

V June 2016

Source: Canadian Institutes of Health Research (CIHR) - Pilot Project Title: Multidimensional evaluation of the consequences of occupational asthma Duration: 06/04-06/05 Amount: $20,000 PI = Dr. Jean-Luc Malo PERSONAL AWARDS AND FELLOWSHIPS Professorial Awards 2016 - Named to the College of New Scholars, Artists and Scientists, Royal Society of Canada (honor) 2015 - Research Excellence Award, Faculty of Social Sciences, UQAM ($3000 CAD) 2012 - CIHR New Investigator Award ($300,000 CAD) 2011 - FRSQ Checheur-Boursier (Junior 2) Investigator Award ($309,891 CAD) 2010 - National Institutes of Health (NIH) Training Fellowship ($1000 USD) 2009 - Young Investigator Award – Canadian Psychological Association (Health Psychology) 2009 - Alfred B. Grossman Award (work on depression and CVD – Heart and Stroke Foundation of Quebec ($5,000 CAD) 2009 - Inaugurated into JW McConnell Graduate Fellowship Society 2007 - Heart and Stroke Foundation - Preventive Cardiology Award of Excellence ($20,000 CAD) 2007 - CIHR-IRSC – Travel Award to Leadership Forum ($1500 CAD) 2006 - Nominated to administrative board - Quebec Lung Association 2006 - FRSQ Checheur-Boursier Clinicienne Salary Award ($124,000 CAD) 2006 - CIHR-IRSC Nomination to Young Investigator’s Forum Steering Committee 2006 - CIHR-IRSC Nomination to Leadership Forum’s Program Committee 2006 - FRSQ – Reseau en santé respiratoire Travel Grant ($1,500 CAD) 2006 - UQAM Faculty of Social Studies Travel Grant ($900 CAD) 2005 - CIRH-IRSC Nomination to Young Investigator’s Forum Rising Stars Committee 2005 - American Thoracic Society Travel Award 2005 - FRSQ – Reseau en santé respiratoire Travel Grant ($1,500 CAD) Postdoctoral Awards 2004 - CIHR-IRSC Travel Award ($1,500 CAD) 2004 - National Institutes of Health (NIH) Training Fellowship ($1000 USD) 2003 - National Institutes of Health (NIH) Training Fellowship ($1000 USD) 2002 - CIHR Post-doctoral Fellowship ($165,000 CAD) Doctoral Awards 2002 - American Psychosomatic Society (APS) Scholar Award ($750 USD) 2002 - Association des troubles anxieux du Québec (ATAQ) Research Award ($500 CAD) 2002 - Montreal Heart Insitute Research Award ($300 CAD) 2001 - Fondation Marc Bourgie Doctoral Fellowship ($5,000 CAD) 2001 - American Psychosomatic Society Citation Award 2000 - ZP Zweig Behavioral Medicine Award – Concordia University ($750 CAD) 1997 - FCAR Doctoral Fellowship ($39,000 CAD) 1997 - JW McConnell Graduate Fellowship ($6,000 CAD) 1997 - Concordia University Fellowship ($4,800 CAD) 1996 - FCAR Master’s Fellowship ($11,000 CAD) 1996 - Concordia University Fellowship ($1,200 CAD)

Kim L. Lavoie Ph.D.

V June 2016

PUBLICATIONS Summary Table of Peer-Reviewed Publications

Articles/letters Book chapters/ reports Invited presentations Published

abstracts Total 127 14 157 232

First/senior author 45 5 157 89

Last 5 years 83 8 119 84

A. Submitted/under review (students are underlined): *senior/corresponding author

1. Lavoie KL*, Paine NJ, Pelletier R, Arsenault A, Diodati J, Campbell TS, Pilote L, Bacon SL. Prospective impact of antidepressant therapy on 8 year risk for major adverse cardiovascular events: Does treating depression affect cardiovascular outcomes differently in men and women? JAMA (submitted)

2. Boudreau M, Bacon SL, Cartier A, Trutshnigg B, Morizio A, Lavoie KL*. Impact of panic attacks on

bronchoconstriction and subjective distress in asthma patients with and without panic disorder. Psychosom Med (under revision).

3. Stebenne P, Bacon SL, Austin A, Paine NJ, Arsenault A, Laurin C, Meloche B, Gordon J, Dupuis J, Lavoie KL*. The impact of positive and negative affect on chest pain perception and silent myocardial ischemia during exercise stress testing. Psychosom Med (under revision)

4. Ouellette DR & Lavoie KL.* Recognition, diagnosis and treatment of neuropsychiatric disorders in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease (submitted).

5. Foldes-Busque G, Hamel S, Belleville G, Fleet R, Poitras J, Chauny JM, Vadeboncoeur A, Diodati JG, Lavoie KL, Marchand A. Predictors of changes in level of pain in non-cardiac chest pain patients with panic disorder. J Psychosomatic Research (submitted).

6. Djandi F, Lamontagne A, Blais L, Bacon SL, Ernst P, Grad R, Lavoie KL, McKinney M, Desplats E, Ducharme F. Determinants and enablers of the use of written action plans for asthma by physicians. Can Respir J. (submitted)

7. Pilote L, Pelletier R, Fabreau G, Bastrash MP, Bacon SL, Daskalopoulou SS, Khan N, Lavoie KL. Withdrawal from the workforce following prematrue acute coronary syndrome. Can J Cardiol. (submitted)

B. Published or in press (students are underlined): *senior/corresponding author

1. Lavoie KL*., Favreau H, Paine NJ, Cartier A, Lemiere C, Joseph M ,Gagnon-Chauvin A, Bacon SL. Prospective impact of psychiatric disorders on employment status and healthcare use in patients investigated for OA. Journal of Occupational and Environmental Medicine (accepted).

2. *Lavoie KL, Rash J, Campbell TS. Changing provider behavior in the context of chronic disease management: Focus on clinical inertia. Annual Review of Pharmacology and Toxicology (in press).

3. Paleaz S, Bacon SL, Lacoste G, Lavoie KL*. How can Adherence to Asthma Medication be Enhanced? Triangulation of Key Asthma Stakeholders’ Perspectives. J of Asthma (in press).

Kim L. Lavoie Ph.D.

V June 2016

4. Plourde A, Bacon SL, Moullec G, Suarthana E, Lavoie KL*. Optimizing screening for depression among adults with asthma. J of Asthma (in press).

5. Ducharme FM, Lamontagne AJ, Blais L, Grad R, Lavoie KL, Bacon SL, McKinney ML, Desplats E, Ernst P.

Enablers of physician prescription of a long-term asthma controller in patients with persistent asthma. Can Respir J (in press).

6. Rash, J.A., Lavoie, K.L., Sigal, R. J., Campbell, D. J. T., Manns, B. J., Tonelli, M. & Campbell, T.S. (2016). The OPTIMIZE trial: Rationale and design of a randomized controlled trial of motivational enhancement therapy to improve adherence to statin medication. Contemporary Clinical Trials. Advanced Online Publication. doi. 10.1016.j.cct.2016.06.001

7. Leung AA, Nerenburg K, Daskalopoulou SS…Lavoie KL et al. Hypertension Canada’s 2016 Canadian Hypertension Education Program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2016 32:569-88.

8. Bourbeau J, Lavoie KL, Sedeno M, DeSousa D, Hamilton A, Maltais F, Troosters T, Leidy N. Behaviour-change

intervention in a multicentre, randomised, placebo-controlled COPD study: methodological considerations and implementation. BMJ Open 2016, 6(4):e010109.

9. Paine N, Bacon SL, Pelletier R, Arsenault A, Diodati J, Lavoie KL*. Do women with anxiety or depression have higher rates of myocardial ischemia during exercise testing than men? Circulation: Cardiovascular and Quality Outcomes. 2016 9(1):S53-61. doi: 10.1161/CIRCOUTCOMES.115.002491.

10. Boudreau M, Lavoie KL, Cartier A, Trutshnigg B, Morizio A, Lemiere C, Bacon SL. Do asthma patients with panic

disorder really have worse asthma? A comparison of physiological and psychological responses to a méthacholine challenge. Respir Med. 2015 Oct;109(10):1250-6.

11. Pelletier R, Khan NA, Cox J, Daskalopoulou SS, Eisenberg MJ, Bacon SL, Lavoie KL, Daskupta K, Rabi D, Humphries KH, Norris CM, Thanassoulis G, Behlouli H, Pilote L; GENESIS-PRAXY Investigators. Sex Versus Gender-Related Characteristics: Which Predicts Outcome After Acute Coronary Syndrome in the Young? J Am Coll Cardiol. 2016 Jan 19;67(2):127-35.

12. Leung Yinko SS, Pelletier R, Behlouli H, Bacon SL, Karp I, Thanassoulis G, Daskalopoulou SS, Eisenberg MJ, Khan NA, Lavoie KL, Pilote L; GENESIS-PRAXY investigators. Potential factors associated with fruit and vegetable intake after premature acute coronary syndrome: a prospective cohort study. Int J Food Sci Nutr. 2015 Dec;66(8):943-9

13. Belleville G, Marchand A, Poitras J, Vadeboncoeur A, Chauny JM, Foldes-Busque G, Pelland ME, Lessard MJ, Fleet RP, Lavoie KL*. Do Treatments for Panic Disorder Improve Sleep in Patients with Unexplained Chest Pain? Archives of Scientific Psychology 2015, 3: 93-100.

14. Campbell TS, Bacon SL, Corace K, Lavoie KL, Rash MSc JA, Vallis M. Comment on Pladevall et al, "A Randomized Controlled Trial to Provide Adherence Information and Motivational Interviewing to Improve Diabetes and Lipid Control". Diabetes Educ. 2015 Oct;41(5):625-6.

15. Leung Yinko SS, Maheswaran J, Pelletier R, Bacon SL, Daskalopoulou SS, Khan NA, Eisenberg MJ, Karp I, Lavoie KL, Behlouli H, Pilote L; GENESIS-PRAXY investigators. Sex differences in health behavior change after premature acute coronary syndrome. Am Heart J. 2015 Aug;170(2):242-248.

Kim L. Lavoie Ph.D.

V June 2016

16. Rizk AK, Wardini R, Chan-Thim E, Bacon SL, Lavoie KL, Pepin V. Acute responses to exercise training and relationship with exercise adherence in moderate chronic obstructive pulmonary disease. Chron Respir Dis. 2015 Nov;12(4):329-39.

17. Bacon SL, Lemiere C, Moullec G, Ninot G, Pepin V, Lavoie KL. Association between patterns of leisure time physical activity and asthma control in adult patients. BMJ Open Respir Res. 2015 Jul 24;2(1):e000083.

18. Bourbeau J, Lavoie KL, Sedeno M. Comprehensive Self-Management Strategies. Semin Respir Crit Care Med. 2015 Aug;36(4):630-8.

19. Pelletier R, Bacon SL, Laurin C, Arsenault A, Fleet RP, Lavoie KL*. The relative impact of mood and anxiety disorders on mortality and cardiovascular events: Results from the DECADE Study: Depression Effects on Coronary Artery Disease Events. BMJ Open. 2015 Dec 15;5(12):e006582.

20. Rash, J. A., Lavoie, K. L., Feldman, R. D. & Campbell, T. S. (2014). Adherence to antihypertensive medications: Current status and future directions. Current Cardiovascular Risk Reports, 8(12), 1-13.

21. Rouleau, C. R., Lavoie, K.L., Bacon, S. L., Vallis, M., Corace, K., Campbell, T. S., for the Canadian Network for

Health Behavior Change and Promotion (2015). Training healthcare providers in motivational communication for promoting physical activity and exercise in cardiometabolic health settings: do we know what we are doing? Current Cardiovascular Risk Reports, 9(29). doi: 10.1007/s12170-015-0457-2

22. McCusker J, Cole MG, Yaffe M, Strumpf E, Sewitch M, Sussman T, Ciampi A, Lavoie K, Platt RW, Belzile E. A randomized trial of a depression self-care toolkit with or without lay telephone coaching for primary care patients with chronic physical conditions. Gen Hosp Psychiatry. 2015 37(3):257-65.

23. Daskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, McKay DW, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Ramesh Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Brian Penner S, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Hiremath S, Stone JA, Drouin D, Lavoie KL, Hamet P, Fodor G, Grégoire JC, Fournier A, Lewanczuk R, Dresser GK, Sharma M, Reid D, Benoit G, Feber J, Harris KC, Poirier L, Padwal RS. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2015 31(5):549-68.

24. Pelaez S, Lamontagne AJ, Collin J, Gauthier A, Grad R, Blais L, Lavoie KL, Bacon SL, Ernst P, Guay H, McKinney

M, Ducharme F. Patient's perspective of barriers and facilitators to taking long-term controller medication for asthma. A novel taxonomy. BMC Pulmonary Medicine 2015 15: 42.

25. Simco R, McCusker J, Sewitch M, Cole M, Yaffe M, Lavoie KL, Sussman T, Strumpf E, Ciampi A, Belzile E. Adherence to a telephone-supported depression self-care intervention for adults with chronic physical illnesses. SAGE Open, January – March 2015, 1-9.

26. Lavoie KL*, Moullec G, Lemiere C, Blais L, Labrecque M, Beauchesne MF, Pepin V, Cartier A, Bacon SL. The efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: Results from a randomized controlled pilot feasibility trial. Patient Preference and Adherence 2014, 8:1555-69.

27. Mercer D, Lavoie KL, Pelletier R, Arsenault A, Bacon SL. The interaction between anxiety and depressive symptoms on brachial artery reactivity in cardiac patients. Biological Psychology 2014, 102C:44-50.

Kim L. Lavoie Ph.D.

V June 2016

28. Austin AW, Gordon JL, Lavoie KL, Arsenault A, Dasgupta K, Bacon SL. Differential association of insulin resistance with cognitive and somatic symptoms of depression. Diabet Med. 2014 31: 994-1000.

29. Mahdanian AA, Rej S, Bacon SL, Ozdin D, Lavoie KL, Looper K. Serotonergic antidepressants and perioperative bleeding risk: a systematic review. Expert Opin Drug Safety. 2014 13: 695-704.

30. Moullec G, Plourde A, Lavoie KL, Bacon SL. Beck Depression Inventory II: determination and comparison of its diagnostic accuracy in subgroups of individuals suspected of coronary artery disease (CAD). Eur J Prev Cardiol 2015 May;22(5):665-72.

31. Boudreau M, Bacon SL, Ouellet K, Jacob A, Lavoie KL*. Mediator effect of depressive symptoms on the

association between BMI and asthma control in adults. CHEST 2014; 146: 348-54.

32. Paelez S, Bacon SL, Aulls M, Lacoste G, Lavoie KL*. Different Points of View: Similarities and Discrepancies Between Asthma Health Care Professionals’ and Patients’ Views on Medication Adherence. Can Respir J 2014, 21:221-26.

33. Bacon SL, Campbell TS, Arsenault A, Lavoie KL. The impact of mood and anxiety disorders on incident hypertension at one year. Int J Hypertens. 2014,953094.[Epub Feb 2]

34. Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, Rabkin SW, Trudeau L, Feldman RD, Cloutier L, Prebtani A, Herman RJ, Bacon SL, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Lindsay P, Hill MD, Coutts SB, Gubitz G, Gelfer M, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Burns KD, Petrella RJ, Hiremath S, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Khara M, Pipe A, Oh P, Selby P, Sharma M, Reid DJ, Tobe SW, Padwal RS, Poirier L; Canadian Hypertension Education Program. The 2014 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Can J Cardiol. 2014 May;30(5):485-501.

35. Favreau H, Bacon SL, Labrecque M, Lavoie KL*. Prospective impact of panic disorder and panic-anxiety on asthma control, health service use, and quality of life in adult asthma patients. Psychosomatic Medicine 2014, 76:147-55.

36. Hamer M, Lavoie KL, Bacon SL. Taking up physical activity in later life and healthy ageing: The English

Longitudinal Study of Ageing. British Journal of Sports Medicine 2014, 48:239-43.

37. Pelletier R, Lavoie KL, SL Bacon, G Thanassoulis, N Khan, L Pilote, for GENESIS-PRAXY Investigators ∗Depression and Disease Severity in Patients with Premature Acute Coronary Syndrome. Am J Med 2014, 127:87-93.

38. Pelletier R, Humphries K, Bacon SL, Lavoie KL, Rabi D, Karp I, Shimony A, Avgil Tsadok M, Pilote L, for the GENESIS-PRAXY Investigators. Sex Differences in Access to Care in Patients with Premature Acute Coronary Syndrome. CMAJ 2014, 186:497-504.

39. Fleet RP, Foldes-Busque G, Gregoire J, Harel F, Laurin C, Burelle D, Lavoie KL. A study of myocardial perfusion in

patients with panic disorder and low risk coronary artery disease after 35% CO2 challenge. J Psychosomatic Res 2014, 76: 41-45.

Kim L. Lavoie Ph.D.

V June 2016

40. Moullec G, Lavoie KL, Malo JL, Gautrin D, l’Archevesque J, Labrecque M. Long-term socio-professional and psychological status in workers investigated for occupational asthma in Quebec. J Occup Environ Med 2013, 55(9):1052-1064.

41. Khan NA, Daskalopoulou SS, Karp I, Eisenberg MJ, Pelletier R, Tsadok MA, Dasgupta K, Norris CM, Pilote L; GENESIS PRAXY Team. Pilote L, Karp I, Bacon S, Cox JL, Dasgupta K, Daskalopoulou SS, Eisenberg MJ, Engert J, Ghali W, Humphries K, Khan N, Lavoie KL, Norris C, Rabi D, So D, Stark KD, Tagalakis V, Tsadok MA, Pelletier R, Thanassoulis G, Shimony A, Ramanthan K, Kornder J, Rabi D, Anderson T, Norris C,Graham M, So D, Natarajan M, Rokoss M, Turek M, Cheema A, Lavi S, Roth S, Huynh T, Nguyen V, Eisenberg M, Méthot J, Doucet M, Montigny M,Mansour S, Lauzon C, Cieza T, Nguyen M, Grondin F, Desjardins A, de Lévis HD, Cox J, Fong P, Menzies D, Rodondi N. Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med. 2013, 11;173(20):1863-71.

42. Lamontagne AJ, Peláez S, Grad R, Blais L, Lavoie KL, Bacon SL, Guay H, Gauthier A, McKinney ML, Ernst P, Collin J, Ducharme FM. Facilitators and solutions for practicing optimal guided asthma self-management: the physician perspective. Canadian Respiratory Journal. 2013 Jul-Aug;20(4):285-93.

43. Choi J, Daskalopoulou SS, Thanassoulis G, Karp I, Pelletier R, Behlouli H, Pilote L; GENESIS-PRAXY Investigators. Sex and gender-related risk factor burden in patients with premature acute coronary syndrome. Can J Cardiol 2014, 30 (1):109-17.

44. Moullec G, Laurin C, Bacon SL, Lavoie KL. Psychiatric disorders and COPD : Still more stronger evidence for convincing policy makers? CHEST 2013 Sep;144(3):1084.

45. Khan NA, Daskalopoulou SS, Karp I, Eisenberg MJ, Pelletier R, Tsadok MA, Dasgupta K, Norris CM, Pilote L; GENESIS PRAXY Team. JAMA Int Med 2013, 173 (20), 1863-71.

46. Plourde A, Lavoie KL, Ouellet K, Carroll D, Ring C, Bacon SL. Hemodynamic, hemostatic, and endothelial reactions to acute psychological stress in depressed patients following coronary angiography. Psychophysiology. 2013 Aug;50(8):790-8.

47. Yohannes AM, Lavoie KL. Overseeing anxiety and depression in patients with physical illness. CHEST. 2013 Sep;144(3):726-8.

48. Hackam DG, Quinn RR, Ravani P, Rabi DM, Dasgupta K, Daskalopoulou SS, Khan NA, Herman RJ, Bacon SL, Cloutier L, Dawes M, Rabkin SW, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson T, Feldman RD, Lindsay P, Hill MD, Gelfer M, Burns KD, Vallée M, Prasad GVR, Lebel M, McLean D, Arnold JMO, Moe GW, Howlett JG, Boulanger J-M, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Godwin M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner B, Hegele RA, McFarlane PA, Sharma M, Reid D, Tobe SW, Poirier L, Padwal RS, for the Canadian Hypertension Education Program. (In Press). The 2013 Canadian Hypertension Education Program (CHEP) Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention and Treatment of Hypertension. Canadian Journal of Cardiology. 2013, 29(5):528-42.

49. Lavoie KL*, Joseph M, Favreau H, Labrecque M, Malo JL, Cartier A, Lemiere C, Bacon SL. The prevalence of psychiatric disorders in patients under investigation for occupational asthma: An overlooked differential diagnosis? American Journal of Respiratory and Critical Care Medicine 2013 May 1;187(9):926-32.

50. Bacon SL, Lavoie KL, Bourbeau J, Ernst P, Maghni K, Gautrin D, Labrecque M, Pepin

V, Pederson BK. The effects of a single-site aerobic exercise intervention on asthma morbidity: the Ex-Asthma study randomised controlled trial protocol. BMJ Open. 2013 Jun 20;3(6).

Kim L. Lavoie Ph.D.

V June 2016

51. Rossi A, Moullec G, Lavoie KL, Gour-Provençal G, Bacon SL. The evolution of a CHEP recommendation: The impact of resistance training on resting blood pressure in adults as an example. Can J Cardiol. 2013 May;29(5):622-7.

52. Jacob A, Laurin C, Lavoie KL, Moullec G, Boudreau M, Lemiere C, Bacon SL. The impact of Body Mass Index on

exacerbations in patients with chronic obstructive pulmonary disease. Canadian Respiratory Journal 2013, 20(4):237-42.

53. Bacon SL, Meloche B, Lavoie KL, Arsenault A. Differential short-term repeated forearm hyperaemic reactivity in coronary artery disease patients compared to healthy low risk participants. International Journal of Molecular Imaging. 2012;2012:578504.

54. Tarlo SM & Malo JL, on behalf of the Fourth Jack Pepys Workshop on Asthma in the Workplace Participants.

Presenentations and discussion from the Fourth Jack Pepys Workshop on Asthma in the Workplace, Ann Am Thorac Soc 2013; 10: S17-S24.

55. Rizk A, Lavoie KL, Pepin V, Wright A, Bacon SL. Sex Differences in the Effects of Inhaled Corticosteroids on Weight Gain among Patients with Asthma. ISRN Pulmonology, Volume 2012, Article ID 138326, 7 pages.

56. McCusker J, Cole M, Yaffe M, Sussman T, Lavoie KL, Strumph E, Sewitch M, Sahin D, deRaad M. A feasibility study of a telephone-support self-care intervention for depression among older adults with a chronic comorbid physical illness in primary care. Mental Health in Family Medicine 2013;9(4):257-73.

57. Marchand A, Belleville G, Fleet RP, Dupuis G, Bacon SL, Poitras J, Chauny JM, Vadeboncoeur A, Lavoie KL*. Treatment of Panic in Chest Pain Patients from Emergency Departments: Efficacy of Different Interventions Focusing on Panic Management. General Hospital Psychiatry 2012 34: 671-680.

58. Moullec G, Gour-Provencal G, Bacon SL, Campbell TS, Lavoie KL*. Efficacy of interventions to improve adherence to inhaled corticosteroid medications in adult asthmatics: a systematic review and meta-analysis. Respiratory Medicine 2012 Sep;106(9):1211-25.

59. Lavoie KL*, Campbell TS, Bacon SL. Behavioral medicine trial design: Time for a change. Arch Intern Med 2012 Sep 24;172(17):1350-1.

60. Rossi A, Davies E, Lavoie KL, Arsenault A, Gordon JL, Meloche B, Bacon SL. The impact of metabolic syndrome and endothelial function on exercise-induced cardiovascular changes. Obesity 2012 May 7. doi: 10.1038/oby.2012.129. [Epub ahead of print]

61. Lessard MJ, Marchand A, Lavoie KL*. Interventions offertes au département d’urgence pour les patients qui

consultent en raison d’attaques de panique ou de douleurs thoraciques non-cardiaques avec ou sans trouble panique: une recension des écrits. Canadian Psychology (in press).

62. Ouellet K, Bacon SL, Boudreau M, Plourde A, Moullec G, Lavoie KL*. Individual and combined impact of cigarette smoking, anxiety, and mood disorders on asthma control. Nicotine and Tobacco Research 2012 Aug;14(8):961-9.

63. Gordon J, Lavoie KL, Pelletier R, Campbell TS, Arsenault A, Ditto B, Bacon SL. The Effect of Major Depression on

Post-Exercise Cardiovascular Recovery. Psychophysiology 2011 Nov;48(11):1605-10.

64. Gordon J, Lavoie KL, Arsenault A, Meloche B, Ditto B, Campbell TS, Bacon SL. The The relationship between multiple health behaviours and brachial artery reactivity. Int J Hypertension 2012:846819. Epub 2012 Feb 29.

Kim L. Lavoie Ph.D.

V June 2016

65. Laurin C, Lavoie KL*. L’entretien motivationnel et la modification des comportements de la santé : efficacité et implications cliniques. Perspectives Psychiatriques 2012.

66. Favreau H, Bacon SL, Joseph M, Labrecque M, Lavoie KL*. Associations between asthma medication and suicidal ideation in adult asthmatics. Respiratory Medicine 2012,106(7):933-41.

67. Lavoie KL*, Campbell TS, Bacon SL. Does motivational interviewing improve medication adherence? Arch Intern Med 2012 Sep 24;172(17):1351-2.

68. Johnson JA, Lavoie KL, Bacon SL, Carlson LE, & Campbell TS. The effect of trait rumination on adaptation to repeated stress. Psychosomatic Medicine 2012, 74(3):258-62. Role: Study conceptualization and design, co-author of text.

69. Laurin C, Moullec G, Bacon SL, Lavoie KL*. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med. 2012 May 1;185(9):918-23.

70. Moullec G, Lavoie KL, Khalil R, Julien M, Favreau H, Labrecque M. Effectiveness of an integrated care program on re-hospitalization in COPD patients. Respirology, 2012, 17(4):707-14

71. Moullec G, Favreau H, Lavoie KL, Labrecque M. Does a self-management program have the same impact on

emotional and functional dimensions of HRQOL? COPD 2012, 9(1):36-45.

72. Rossi A, Moullec G, Lavoie KL, Bacon SL. Resistance training, blood pressure, and meta-analyses. Hypertension 2012 Mar;59(3):e22-3.

73. Miedinger D, Lavoie KL, Archeveque JL, Ghezzo H, Malo JL. Identification of clinically significant psychological distress and psychiatric morbidity by examining quality of life in subjects with occupational asthma. Health and Quality of Life Outcomes 2011, 9:76.

74. Lessard MJ, Marchand A, Pelland ME, Belleville G, Vadebonceour A, Chauny JM, Poitras J, Dupuis G, Foldes-

Busque G, Poirier-Brisson J, Lavoie KL*. Comparing two brief psychological interventions to usual care in panic disorder patients presenting to the emergency department with chest pain. Behav Cogn Psychother. 2012 Mar;40(2):129-47

75. Goodwin RD, Lavoie KL, Jenkins E, Brown ES, Fedoronko DA. Depression, anxiety, and COPD: the unexamined

role of nicotine dependence. Nicotine and Tobacco Research. 2012,14(2):176-83.

76. Labrecque M, Rabhi K, Laurin C, Favreau H, Moullec G, Lavoie KL, Julien M. Can a self-management education program for patients with chronic obstructive pulmonary disease improve quality of life? Can Respir J 2011; 18(5): 77-81.

77. Bacon SL, Lavoie KL*, Arsenault A, Dupuis J, Pilote L, Laurin C, Gordon J, Gautrin D, Vadeboncouer A. The

Research on Endothelial function in Women And men at Risk for cardiovascular Disease (REWARD) Study: Methodology. BMC Cardiovascular Disorders 2011, 11(1):50. *co-1st authors

78. Lavoie KL*, Boudreau M, Plourde A, Campbell TS, Bacon SL. Impact of generalized anxiety disorder on asthma

morbidity. Psychosomatic Medicine 2011; 73(6):504-13. 79. Moullec G, Laurin C, Lavoie KL, Ninot G. Effects of pulmonary rehabilitation on quality of life. Current Opinion in

Pulmonary Medicine 2011;17:62-71.

80. Pelletier R, Bacon SL, Arsenault A, Campbell TS, Fleet RP, Lavoie KL*. The impact of anxiety disorders and electrocardiographic assessment of myocardial ischemia and exercise stress test performance. Journal of Cardiopulmonary Rehabilitation 2011;31:60-6.

Kim L. Lavoie Ph.D.

V June 2016

81. Miedinger D, Lavoie KL, L’Archeveque J, Zunzunuegui MV, Malo JL. Quality of life, psychological and cost

outcomes two years after diagnosis of occupational asthma. Journal of Occupational and Environmental Medicine 2011;53:231-8.

82. Laurin C, Moullec G, Bacon SL, Lavoie KL*. The impact of psychological distress on exacerbation rates in COPD.

Therapeutic Advances in Respiratory Disease 2011;5:3-18.

83. Pelland, M-E, Marchand, A, Lessard, M-J, Belleville, G, Chauny, J-M, Vadeboncoeur, A, Poitras, J, Foldes-Busque, G, Bacon, SL & Lavoie, KL*. Efficacy of two interventions for panic disorder in patients presenting to the ED with chest pain. American Journal of Emergency Medicine . 2011:1051-61.

84. Wright A, Lavoie KL, Jacob A, Rizk A, Bacon SL. Effects of body mass index on exercise as a reported asthma trigger. The Physician and Sportsmedicine 2010, 38:61-6.

85. Pelaez S, Lavoie KL, Arsenault A, Bacon SL. Social networks and Exercise in Coronary Heart Disease Patients.

Journal of Cardiopulmonary Rehabilitation 2010, 30:324-28.

86. Bacon SL, Keller A.J., Lavoie KL, Campbell TS. Comparison of a three-quarter electrode band configuration with a full electrode band configuration for impedance cardiography. Psychophysiology 2010, 47:1087-93.

87. Lavoie KL*, Bouthillier D, Bacon SL, Lemiere C, Martin J, Hamid Q, Ludwig M, Olivenstein R, Ernst P.

Psychological distress and maladaptive coping styles in patients with severe versus moderate asthma. CHEST 2010, 137:1324-31.

88. Ditto B, Lavoie KL, Campbell TS, Gordon J, Arsenault A, Bacon SL. Negative Association Between Resting Blood

Pressure and Chest Pain in People Undergoing Exercise Stress Testing for Coronary Artery Disease. Pain 2010; 149:501-505.

89. Lavoie KL*, Pelletier R, Arsenault A, Dupuis J, Bacon SL. Impact of depression and coronary heart disease status

on endothelial function measured by forearm hyperemic reactivity. Psychosomatic Medicine 2010;72(1):20-6.

90. Bacon SL, Bouchard A, Loucks E, Lavoie KL*. Is socio-economic status associated with worse asthma morbidity in a Canadian sample of adult asthmatics? Respiratory Research 2009;10:125.

91. Key BL, MacKenzie-Ross K, Bacon SL, Lavoie KL, Campbell TS. Depressed affect is associated with poor

cardiovascular recovery in young women following a mental stressor. Annals of Behavioral Medicine 2009;38(2):154-9.

92. Laurin C, Labrecque M, Dupuis G, Bacon SL, Cartier A, Lavoie KL*. Are chronic obstructive pulmonary disease

patients with psychiatric disorders at greater risk of exacerbations? Psychosomatic Medicine 2009, 71(6):667-74. 93. Tarlo S, Malo JL, Third Jack Pepys Workshop on Asthma in the Workplace Participants. An official ATS

proceedings: asthma in the workplace: the Third Jack Pepys Workshop on Asthma in the Workplace: answered and unanswered questions. Proc Am Thorac Soc. 2009 Aug 1;6(4):339-49.

94. Malo JL, L’Archeveque J, Castellanos RT, Lavoie KL, Ghezzo H, Maghni K. Long-term outcomes of irritant-

induced asthma. American Journal of Respiratory and Critical Care Medicine 2009;179: 171-178.

95. Lavoie KL*, Joseph M, Bacon SL. Psychosocial factors and occupational asthma. Current Opinion in Asthma and Clinical Immunology 2009, 9:103-9.

Kim L. Lavoie Ph.D.

V June 2016

96. Pelletier R, Lavoie KL, Gordon J, Arsenault A, Campbell TS, Bacon SL. The role of mood disorders in exercise-induced cardiovascular reactivity. Psychosom Med 2009, 71:301-7.

97. Bacon SL, Pelletier R, Lavoie KL. The impact of acute and chronic exercise on thrombosis in cardiovascular

disease. Thrombosis and Haemostasis 2009, 101: 452-459.

98. Lavoie KL*, Bouchard A, Joseph M, Campbell TS, Favreau H, Bacon SL. (2008). Association of asthma self-efficacy to asthma control and quality of life. Annals of Behavioral Medicine, 36: 100-106.

99. Laurin C, Lavoie KL, Bacon SL. Reply to “Relationship between depression and exacerbations in chronic

obstructive pulmonary disease. Eur Respir J 2008 ;32:1129-30.

100. Barone S, Labrecque M, Campbell TS, Ditto B, Bacon SL, Lavoie KL*. The association between atopy and anxiety sensitivity in adult asthmatics. J Behav Med 2008;31:331-339.

101. Gordon J, Lavoie KL, Arsenault A, Ditto B, Bacon SL. Health behaviors and endothelial function. J Behav Med

2008;31:5-21. 102. Zhao X, Arsenault A, Lavoie KL, Meloche B, Bacon SL. Tracer kinetics of forearm endothelial function:

comparison of an empirical method and a quantitative modeling technique. Conf Proc IEEE Eng Med Biol Soc. 2007;1:628-31.

103. Laurin C, Lavoie KL*, Bacon SL, Dupuis G, Lacoste G, Cartier A, Labrecque M. Sex differences in the prevalence

of psychiatric disorders and psychological distress in patients with chronic obstructive pulmonary disease. CHEST 2007;132:148-55.

104. Bacon SL, Bergeron C, Boulet LP, Chen Y, Dixon A, Ernst P, Hamid Q, Holguin F, Irvin CG, Kimoff RJ, Komakuloff

S, Laprise C, Lavoie KL, Shore S, Theodorescu M, Vohl MC. Symposium on obesity and asthma: November 2006. Can Respir J 2007; 14:201-8.

105. Yacoub MR, Lavoie KL, Guillaume L, Daigle S, L’Archevêque J, Ghezzo H, Lemière C, Malo JL. Assessment of

impairment/disability due to occupational asthma through a multidimensional approach. Eur Respir J 2007; 29:889-96.

106. Lavoie KL*, Bacon SL, Cartier A, Barone S, Ditto B, Labrecque M. What’s worse for asthma: mood disorders,

anxiety disorders, or both? CHEST 2006; 130:1039-1047.

107. Tarlo, SM, Malo, JL, and Workshop Members. Perspective: An American Thoracic Society/European Thoracic Society Report. 100 key questions and needs in occupational asthma. Eur Respir J 2006; 27: 607–614.

108. Campbell TS, Lavoie KL, Bacon SL, Scharf D, Aboussafy D, Ditto B. Asthma, self-efficacy, parasympathetic activity, and airflow obstruction during emotional stress during daily life. Int J Psychophysiol 2006;62(1):109-14.

109. Bacon SL, Lavoie KL, Campbell TS, Arsenault A, Ditto B. Ischemia, pain, and blood pressure response to exercise

stress testing: A cross-sectional retrospective analysis. J Hum Hypertension 2006; 20:672-78.

110. Lavoie KL*, Bacon SL, Labrecque M, Cartier A, Ditto B. Higher body mass index is associated with worse asthma control and quality of life among adult asthma patients. Respir Med 2006; 100: 648–657.

111. Lavoie KL* & Barone S. Prescribing Rights for Psychologists: A review of current issues and controversies. CNS

Drugs 2006;20:51-66.

Kim L. Lavoie Ph.D.

V June 2016

112. Bacon SL, Ring C, Li Saw Hee F, Lip GYH, Blann AD, Lavoie KL, Caroll D. Hemodyndamic, hemostatic and endothelial reactions to psychological and physical stress in coronary artery disease patients. Biol Psychol 2006;71:162-170.

113. Fleet RP, Lesperance F, Arsenault A, Gregoire J, Lavoie KL, Laurin C, Burelle D, Beitman B, Frasure-Smith N.

Are panic attacks bad for your heart? Myocardial perfusion study of induced panic attacks in coronary artery disease patients. Am J Cardiol 2005;96:1064-68.

114. Lavoie KL*, Cartier A, Labrecque M, Bacon SL, Lacoste G, Barone S, Verrier P, Ditto B. Are psychiatric disorders

associated with worse asthma control and quality of life in asthma patients? Respir Med 2005; 99; 1249-1257. 115. Aboussafy D, Campbell T, Lavoie KL, Ditto B, & Aboud F. Psychophysiological reactivity of asthmatics to

laboratory stressors: Stress type, autonomic responses and airflow changes. Int J Psychophysiol 2005;57:195-201.

116. Aboussafy D, Balter M, Godin G, Lavoie K, Koley S. Asthma: The psychology of compromise. Special report on

the psychological burden of asthma. Can J Respir Ther 2005; 41: 30-37.

117. Lavoie KL*, Fleet RP, Laurin C, Arsenault A, Miller SB, Bacon SL. Heart rate variability in coronary artery disease patients with and without panic disorder. Psychiatry Res 2004;128:289-299.

118. Lavoie KL*, Fleet RP, Lesperance F, Laurin C, Arsenault A, Frasure-Smith N, Burelle D, Bacon SL. Are exercise

stress tests appropriate for assessing myocardial ischemia in patients with major depressive disorder? Am Heart J 2004;148:621-27.

119. Lavoie KL*. Replies to Littman and Sussman re: “Should psychologists be granted prescription privileges?” Can J Psychiatry 2003; 48:497-498.

120. Fleet RP, Lavoie KL, Martel JP, Dupuis G, Marchand A, & Beitman BD. Two-year follow-up status of emergency

department patients with chest pain: Was it panic disorder? Can J Emerg Med 2003;5;247-54.

121. Lavoie KL* & Fleet RP. Should psychologists be granted prescription privileges? A review of the prescription privilege debate for psychiatrists. Can J Psychiatry 2002; 47:443-449.

122. Lavoie KL*, Miller SB, Conway M, & Fleet RP. Anger, negative emotions, and cardiovascular reactivity during

interpersonal conflict in women. J Psychosom Res 2001; 51 :503-512.

123. Lavoie KL* & Fleet RP. The impact of depression on the course and outcome of coronary heart disease : Review for cardiologists. Can J Cardiol 2000; 16 : 653-662.

124. Fleet RP, Lavoie KL, & Beitman BD. Is panic disorder associated with coronary artery disease? A critical review of

the literature. J Psychosom Res 2000;48: 347-356.

125. Fleet RP, Martel JP, Lavoie KL, Dupuis G & Beitman BD. Non-fearful panic disorder: A variant of panic in medical patients? Psychosomatics 2000;41: 311-320.

126. Miller SB, Friese M, Dolgoy L, Sita A, Lavoie K, Campbell T. Hostility, sodium consumption, and cardiovascular

response to interpersonal stress. Psychosomatic Medicine 1998; 60(1):71-7. 127. Senecal C, Lavoie KL, & Koestner R. Trait and situational factors in procrastination. J Soc Beh Personality 1998;

12: 889-903. C. Book chapters, collective works, or reports (students are underlined) *senior/corresponding author

Kim L. Lavoie Ph.D.

V June 2016

1. Lavoie KL, Yohannes A, Beland M, Bacon SL. Asthma and chronic obstructive pulmonary disease. In : Behavioral

and Social Science in Medicine : Principles and Practice of Biopsychosocial Care, S. Waldstein & M. Muldoon (Eds), in revision.

2. Lavoie KL*. Prevalence du stress psychologiques et des troubles psychiatriques chez les patients soumis a une evaluation relative a l’asthme professionnel et l’impact sur la situation d’emploi et l’utilisation des services de la sante au terme de suivi de 12 a 18 mois IRRST Rapports scientifiques, septembre 2014.

3. Blanc P, Vandenplas O, Harber P, Lavoie KL. Impairment and Disability Evaluation: I. Introduction: Psychosocial, Economic and Medicolegal Aspects. 2013. Role: Co-author of text (section on psychosocial impacts)

4. Lavoie KL*. (2012). Anxiety. In MD Gellman and JR Turner (Eds), Encyclopedia of Behavioral Medicine. Springer: New York.

5. Lavoie KL*. (2012). Chronic depression. In MD Gellman and JR Turner (Eds), Encyclopedia of Behavioral Medicine. Springer: New York.

6. Moullec G, Lavoie KL, Sultan S. Vulnerabilité affective et santé. In S. Sultan, I. Varescon (Eds), Psychologie de la santé, Presses Universitaires de France, 2012, ISBN : 978-2-13-059315-7.

7. Gordon J, Lavoie KL, Ditto B, Arsenault A, Bacon SL. Mood disorders and Cardiovascular Disease. Mood Disorders, 2012, ISBN 979-953-307-077-2 2012.

8. Foster J, Lavoie KL, Boulet LP. Treatment adherence and psychosocial factors in severe asthma. In K F Chung,

E Bel & S Wenzel (Eds), Difficult-to-treat severe asthma, 2011, European Respiratory Society. 9. Sexton L, Broga M, Charest RM, Beaulieu S, Lavoie KL, Leavey JE, Mothersill K, Nussbaum D, Richards M,

Saklofske D, Turner C. CPA Task Force on Prescriptive Authority for Psychologists in Canada: Report to the Canadian Psychological Association Board of Directors, November 6, 2010.

10. McGowan P, Fredricks S, Schaefer J, Funnell M, Lavoie KL, Lyddiatt A, O’Donnell A, Des Rosiers N, Beatty G, Johnstone R, Holubiec I, O’Halloran K, Chee J, Stewart-Pyne A, Kumar E. Strategies to support self-management in chronic conditions: Collaboration with clients. Registered Nurses of Ontario Best Practices Guideline Program, 2010.

11. Malo JL, Lemiére C, Gautrin D, Lavoie KL, Labrecque M. (2009) Asthma and the Workplace In : Asthma, Health,

and Society : From the Clinic to the Public, Andrew Harver & Harry Kotses, (Eds). Springer. 12. Lavoie KL*, Pelletier R, Bacon SL. Sex differences in traditional and psychological risk factors for cardiovascular

disease. In S. Saini (Ed), Anger, Hostility and Aggression – AHA Syndrome: Relationship with Cardiac Diseases and Prevention by Lifestyle Intervention, ANAMAYA Publication, Ltd. India, 2008.

13. Beaulieu, J, Lavoie KL. Maîtriser son asthme : emotions et comportement. In J. Beaulieu & C. Fortin (Eds) :

Asthme : une maladie a gerer. Editions Logiques, 2006. 14. Aboussafy D, Balter M, Godin G, Lavoie K, Koley S. Asthma: The psychology of compromise. Special report on

the psychological burden of asthma. Canadian Lung Association, September 2004. D. Peer-reviewed abstracts – published or in press (students are underlined)

Kim L. Lavoie Ph.D.

V June 2016

1. Lavoie KL, Gooderham MJ, Bacon SL, Campbell TS, Vallis M, Laurin C, Dragomir, A, Papp K. Clinician training in motivational communication skills: The impact of Derm Connect Canada (Phase 1). Canadian Dermatology Association Journal. (in press)

2. Lavoie KL, Bell M, Taylor T, Arense R, Saum M, Faucher D, Shawi M, Camerlain M. Clinician training in motivational communication skills: The impact of the Language of Change Program among rheumatologists from across Canada. Poster presented at the 17th Annual European Congress of Rheumatology, European Respiratory Journal (in press).

3. Jacob, A, Lavoie KL, Bacon SL. The impact of a cognitive-behavioral (CBT) weight loss management program on weight change and depressive symptoms in asthmatic patients: a pilot study. Poster Presented at International Behavioral Trials Network Meeting, Health and Fitness Journal of Canada, May 2016 (in press).

4. Dragomir A, Julien C, Lavoie KL, Bacon SL. Training healthcare professionals in health behavior chagne strategies : a

systematic review. Poster Presented at International Behavioral Trials Network Meeting, Health and Fitness Journal of Canada, May 2016 (in press).

5. Farnesi BC, Lavoie KL, Legault L, Bacon SL. A qualitative exploration on the treatment and management of severe

obesity in youth. Poster Presented at International Behavioral Trials Network Meeting, Health and Fitness Journal of Canada, May 2016 (in press).

6. Julien C, Dragomir A, Bacon SL, Lavoie KL. Is depression associated with sputum inflammatory markers and lung

function in asthma? Poster Presented at International Behavioral Trials Network Meeting, Health and Fitness Journal of Canada, May 2016 (in press).

7. Gagnon-Chauvin A, Julien C, Bacon SL, Favreau H, Lavoie KL. Impact of psychiatric disorders on health and

employement outcomes in patients referred for evaluation of occupational asthma. Poster Presented at International Behavioral Trials Network Meeting, Health and Fitness Journal of Canada, May 2016 (in press).

8. Duckworth K, Pepin V, Wardini R, Rizk A, Bacon SL, Lavoie KL. Depression symptoms as a predictor of pulmonary

rehabilitation aerobic exercise attendance and compliance, and authonomous exercise levels 9 months afterwards: A pilot study. Poster Presented at International Behavioral Trials Network Meeting, Health and Fitness Journal of Canada, May 2016 (in press).

9. Beland M, Jojich-White U, Briand S, Lavoie KL, Bacon SL. The efficacy of exercise as a treatment for depression in

adults with non-communicable diseases (NCDS): A systematic review. Poster Presented at International Behavioral Trials Network Meeting, Health and Fitness Journal of Canada, May 2016 (in press).

10. Paine NJ, Bacon SL, Boudreau M, Dolan EM, Lavoie KL. Increases in expired CO2 in response to a standard panic

(CO2) challenge in asthma patients with anxiety sensitivity and panic disorder. Poster Presented at International Behavioral Trials Network Meeting, Health and Fitness Journal of Canada, May 2016 (in press).

11. Paine NJ, Lavoie KL, Laurin C, Bacon SL. The role of cardio-metabolic risk on COPD exacerbations in COPD patients.

Poster Presented at International Behavioral Trials Network Meeting, Health and Fitness Journal of Canada, May 2016 (in press).

12. Paine N.J., Bacon S.L., Pelletier R., Arsenault A., Lavoie K.L. (2016). Anxiety is associated with an increased risk of

exercise-induced ischemia in women without a history of CAD, but not in men. Annals of Behavioral Medicine, 50 (Suppl 1) S122.

13. Lipszyc JC, Silverman F, Holness DL, Liss GM, Lavoie KL, Tarlo SM. Psychosocial, quality of life and socioeconomic

outcomes of patients with work-related asthma and relationships to different models of clinical organization. Am J Respir Crit Care Med 2016, 193:A3717.

Kim L. Lavoie Ph.D.

V June 2016

14. Paine N.J., Bacon S.L., Boudreau M., Dolan E.M., Lavoie K.L. (2016). The impact of Anxiety Sensitivity in asthma patients with panic disorder on respiratory response to a standard panic (CO2) challenge. Annals of Behavioral Medicine, 50 (Suppl 1) S224

15. Dolan E.M., Paine N.J., Lavoie K.L., Bacon S.L. (2016). The impact of anxiety disorder and asthma diagnoses on

airway hyper-responsiveness (AHR) to methacholine challenge in patients undergoing evaluation for occupational asthma. Annals of Behavioral Medicine, 50 (Suppl 1) S224

16. Briand, S., Beland, M., Bacon, S.L., Jojich-White, U., Lavoie, K.L.(2016). The Mediator Effect of Smoking Status on the Association Between Anxiety Disorders and Asthma Control in Asthma Patients. Annals of Behavioral Medicine, 50(Suppl 1), S225.

17. Jojich-White, U., Beland, M., Briand, S., Lavoie, K.L., Bacon, S.L.(2016). The Effects of Physical Activity on the

Depression-Smoking Relationship in Asthmatic Adults. Annals of Behavioral Medicine, 50(Suppl 1), S333.

18. Julien, C.A., Dragomir, A.I., Bacon, L.B., Lavoie, K.L. (2016). Associations Between Depression and Sputum Inflammatory Markers in Patients With and Without Asthma. Annals of Behavioral Medicine, 50(Suppl 1), S224.

19. Dragomir, AI., Bacon, S., Moullec, G., Blais, L., Laurin, C., Lavoie, KL. (2016). Adherence profiles are associated with

differential responses to a MC intervention for medication adherence in asthma patients. Annals of Behavioral Medicine. 50(Suppl 1), S191.

20. Beland, M., Jojich-White, U., Briand, S., Lavoie, K.L., Bacon, S.L. (2016). The Efficacy of Exercise as a Treatment for

Depression in Adults with Chronic Illness: A Systematic review. Annals of Behavioral Medicine, 50(Suppl 1), S133. 21. Paine N, Bacon SL, Boudreau M, Dolan E, Lavoie KL. Increases in expired CO2 in response to a standard panic

challenge in asthma patients with anxiety sensitivity and panic disorder. Health and Fitness Journal of Canada (in press).

22. Bacon SL, Boudreau M, Lavoie KL, Elhalwi A, J Sayegh-Smith, Lemiere C, Maghni K. (2015). Objective measures of

asthma, subjective distress, and physiological responses of asthma patients with and without panic disorder during methacholine challenge. Canadian Respiratory Journal, 22: 7A

23. Beland M, Bacon SL, Lavoie KL. (2015). The impact of health care use on the development of mood disorders in

patients with asthma. Canadian Respiratory Journal, 22: 7A. 24. Dragomir AI, Bacon SL, Moullec G, Blais L, Laurin C, Lavoie KL. (2015). Self-efficacy, motivation and healthcare

provider autonomy support: Impact on asthma medication adherence. Canadian Respiratory Journal, 22: 8A 25. Raddatz C, Jacob A, Lavoie KL, Bacon SL. (2015). Investigating the quantitative relationship between body mass index

and airway hyperresponsiveness in adults with asthma. Canadian Respiratory Journal, 22: 8A 26. Sayegh-Smith J, Boudreau M, Bacon SL, Lavoie KL. (2015). Predictors of having panic attack-like symptoms in asthma

patients undergoing a methacholine challenge test.Canadian Respiratory Journal, 22: 8-9A 27. Moga A, Lavoie KL, Yohannes A, Pelletier R, Bacon SL. (2015). The impact of anxiety and mood disorders on chronic

obstructive pulmonary disease development. Canadian Respiratory Journal, 22: 11-12A 28. Paine NJ, Lavoie KL, Moga A, Moullec G, Laurin C, Pelletier R, Arsenault A, Bacon SL (2015). Increased METS during

exercise stress testing is predictive of reduced risk of COPD development. Canadian Respiratory Journal, 22, 12A

Kim L. Lavoie Ph.D.

V June 2016

29. Duckworth K, Pepin V, Wardini R, Rizk AK, Bacon SL, Lavoie KL, Moullec G. (2015). Predictors of endurance training attendance and compliance during pulmonary rehabilitation for COPD: A pilot study. Canadian Respiratory Journal, 22: 21.

30. Boudreau M, Sayegh-Smith J, Bacon SL, Lavoie KL. (2015) Do panic attacks cause asthma attacks? Impact of panic

challenge on bronchoconstriction in asthmatics with and without panic disorder. Canadian Psychology, 56(2a) 139. 31. Sayegh-Smith J, Boudreau M, Lavoie KL, Bacon SL. (2015) Factors associated with having a panic attack-induced

asthma exacerbation. American Journal of Respiratory and Critical Care Medicine, 191;A1385. 32. Pelletier R, Karp I, Bacon S, Thanassoulis G, Humphries K, Cox J, Dasgupta K, Norris C, Daskalopoulou SS, Lavoie K,

Pilote L. (2014). Recurrent events in patients with premature acute corinary syndrome: Psychosocial determinants and sex interactions. Journal of the American College of Cardiology, 63: 12S.

33. Austin AW, von Kanel R, Mills PJ, Lavoie KL, Bacon SL, Pung MA, Dimsdale JE. (2014). Disrupted sleep is associated

with elevated inflammatory stress response. Canadian Psychology, 55: 41. 34. Béland M, Bacon SL, Lavoie KL. (2014). Factors associated with the development of mood disorders in patients with

asthma. Canadian Psychology, 55: 41.

35. Peláez S, Mills PJ, Wilson K, Sadja J, Lavoie KL, Bacon SL. (2013). Is social integration related to exercise adherence in sedentary individuals with slightly elevated blood pressure? Journal of Cardiopulmonary Rehabilitation and Prevention, 33: 344-345.

36. Austin A, Gordon J, Lavoie KL, Arsenault A, Bacon SL. (2013). Are the somatic-affective and cogntivie symptoms of

depression differentially assocaited wwith insulin resistance. Canadian Psychology, 54: 134. 37. Boudreau M, Ouellet K, Plourde A, Bacon SL, Lavoie KL. (2013). Assocaition between panic disorder and asthma

control: The impact of asthma self-efficacy. Canadian Psychology, 54: 134.

38. Plourde A, Lavoie KL, Ouellet K, Carroll D, Ring C, Bacon SL. (2013). Association between depression and hemodynamic, haemostatic, and endothelial responses to psychological stress in patients following coronary angiography. Canadian Psychology, 54: 138

39. Jacob A, Bacon SL, Lavoie KL. (2013). Depression: Does it lead to increases in body mass index among patients with

asthma? Canadian Psychology, 54: 136. 40. Moullec G, Lavoie K, Bacon S. (2013). Reviewing the evidence: Efficacy of motivational interviewing for health

behaviour change in chronic disease. Canadian Psychology, 54: 105. 41. Lavoie K, Moullec G, Bacon S. (2013). Applications and efficacy of motivatinal interveiwing to improve adherence and

outcomes in asthma. Canadian Psychology, 54: 105.

42. Lavoie K, Bacon S. (2013). Optimizing recruitment in behavioural medicine research: The Montreal Behavioural Medicine Centre experience. Canadian Psychology, 54: 13.

43. Rizk A, Wardini R, Chan-Thim E, De Lorimier M, Bacon SL, Lavoie KL, Parenteau S, Beaucage F, Pepin V. (2013).

Relationship between acute physiological response to exercise-training and compliance to pulmonary rehabilitation in chronic obstructive pulmonary disease. American Journal of Critical Care Medicine, 187: A2580.

44. Rizk A, Chan-Thim E, Wardini R, De Lorimier M, Bacon SL, Lavoie KL, Parenteau S, Beaucage F, Pepin V. (2013). The

chronic affective repsonse to different exercise-training protocols in chornic obstructive pulmonary disease. American Journal of Critical Care Medicine, 187: A2581.

Kim L. Lavoie Ph.D.

V June 2016

45. Bacon SL, Blais L, Lemiere C, Jacob A, Lavoie KL. (2013). Reliability and accuracy of self-reported versus measured

weight, height, and body mass index in patients with asthma. American Journal of Critical Care Medicine, 187: A4206. 46. Morizio A, Lavoie KL, Bacon SL. (2013). Does panic disorder confer a protective effect on lung function in asthmatics?

Psychosomatic Medicine, 75: A97. 47. Austin A, Gordon JL, Lavoie KL, Arsenault A, Bacon SL. (2013). Are the somatic-affective and cognitive symptoms of

depression differntially assocaited with insulin resistance? Psychosomatic Medicine, 75: A26. 48. Lavoie KL, Ouellet K, Moullec G, Bacon SL. (2013). Prospective impact of mood and anxiety disorders on 5-year

asthma control and health service use. Psychosomatic Medicine, 75: A30. 49. Lavoie KL, Pelletier R, Bacon SL, Karp I, Humphries K, Stark K, Eisenberg M, Cox J, Daskalopoulou S, Pilote L. (2013).

Impact of depression on premature acute coronary syndrome: Is depression assocaited with higher risk profile amoung women? Psychosomatic Medicine, 75: A82.

50. Bacon SL, Lemiere C, Jacob A, Lavoie KL. (2013). Are self-reports of weight, height, and BMI reliable in patients with

asthma? Psychosomatic Medicine, 75: A125. 51. Bacon SL, Arsenault A, Melcoche B, Lavoie KL. (2013). The assocaition of mood and anxiety disorders on physical

activity changes over 2 years. Psychosomatic Medicine, 75: A33. 52. Peláez S, Aulls MW, Lacoste G, Bacon SL, Lavoie KL. (2013). Potential Interventions to Enhance Adherence to Asthma

Treatment. International Journal of Qualitative Methods, 11: 763. 53. Rizk A, Bacon SL, Wardini R, Chan-Thim E, Lavoie KL, De Lorimier M, Pepin V. (2012). Acute affective response to

different exercise-training protocols in COPD. Canadian Respiratory Journal, 19: e36. 54. Daoud E, Laurin C, Lavoie KL, Bacon SL. (2012). Psychaitric disorders as predictors of the number and length of

exacerbations in COPD patients. Canadian Respiratory Journal, 19: e38.

55. Moullec G, Gour-Provencal G, Bacon SL, Campbell T, Lavoie KL. (2012). Efficacite des interventions comportementales pour ameliorer l`adherence aux corticosterodides inhales chez des adultes atteints d`asthme: Revue systematique et meta-analyse. Canadian Respiratory Journal, 19: e40.

56. Moullec G, Plourde A, Bacon SL, Lavoie KL. (2012). Proprietes discriminantes du beck depression inventory-II chez

des patients atteints d`asthme. Canadian Respiratory Journal, 19: e56. 57. Mercer DA, Peláez S, Ditto D, Lavoie KL, Arsenault A, Bacon SL. (2012). Is social desirability assocaited with self-

reported physical activity in cardiac patients? Journal of Cardiopulmonary Rehabilitation and Prevention, 32: 306. 58. Lavoie KL, Ouellet K, Moullec G, Bacon SL. (2012). Are Mood and Anxiety Disorders Risk Factors For Worse Asthma

Control? Results from A 5-Year Prospective Study. American Journal of Respiratory and Critical Care Medicine, 185: A1085.

59. Rizk AK, Bacon SL, Wardini R, Chan-Thim E, Lavoie KL, de Lorimier M, Pepin V. (2012). Physiological, Affective, And

Symptomatic Response To Different Exercise-Training Protocols In Patients With Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 185: A2382.

60. Bacon SL, Daoud E, Laurin C, Moullec G, Lavoie KL. (2012). The Impact of Psychiatric Disorders on the Number and

Length of COPD Exacerbations in Stable COPD Patients. American Journal of Respiratory and Critical Care Medicine, 185: A3721.

Kim L. Lavoie Ph.D.

V June 2016

61. Plourde, A., Moullec, G., Lavoie, K.L., & Bacon, S.L. (2012). Beck Depression Inventory II: Determination of cut-off scores in coronary artery disease patients. Psychosomatic Medicine, 74(3), A-16.

62. Boudreau, M., Lavoie, K.L., Ouellet, K., & Bacon, S.L. (2012). The association between panic disorder, asthma self-

efficacy, and asthma control in adult asthmatics. Psychosomatic Medicine, 74(3), 49.

63. Moullec, G., Plourde, A., Bacon, S.L., & Lavoie, K.L. (2012).Screening properties of the Beck Depression Inventory-II in patients with asthma. Psychosomatic Medicine, 74(3), A-55.

64. Austin, A.W., Lavoie, K.L., Arsenault, A.B., & Bacon, S.L. (March 2012). Relationships between depression, anxiety,

health symptoms and several biomarkers among those with and without coronary artery disease. Poster presented at the 70th Annual Meeting of the American Psychosomatic Society, Athens, Greece.

65. Ouellet, K., Bacon, S.L., Boudreau, M., Plourde, A., & Lavoie, K.L. (2012). Impact of hypochondriasis on asthma control

and health service use in adult asthmatics. Psychosomatic Medicine, 74(3), A-41.

66. Bacon, S.L., Daoud, E., Laurin, C., Moullec, G., Lavoie, K.L. (2012). The Impact Of Psychiatric Disorders On The Number And Length Of COPD Exacerbations In Stable COPD Patients. American Journal of Respiratory and Critical Care Medecine, 185, A3721.

67. Lavoie KL, Moullec G, Blais L, Beauchesne MF, Lemiere C, Labrecque M, Campbell TS, Bacon SL. (2011). The

efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, non-adherent asthmatics: Results from a randomized controlled pilot study. CHEST, 140(4), 915A.

68. Bacon, S.L., Ouellet, K., Jacob, A., Lemiere, C., & Lavoie, K.L. (2011). Does increased body mass index (BMI)lead to poor asthma control or the reverse? Evidence from a 4-year longitudinal study. CHEST, 140(4), 972A.

69. Lavoie KL, Moullec G, Blais L, Beauchesne MF, Lemiere C, Labrecque M, Campbell TS, Bacon SL. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, non-adherent asthmatics: The Asthma Control Trial (ACT). Psychosomatic Medicine 2011; 73(3): 99.

70. Gordon JL, Lavoie KL, Pelletier R, Arsenault A, Ditto B, Bacon SL. Sex differences in the relationship between mood disorders and C-reactive protein. Psychosomatic Medicine. 2011:73:A113.

71. Morizio A, Lavoie KL, Joseph M, Bacon SL. (2011). The association between anxiety sensitivity (AS) and inflammatory

responses to specific inhalation challenge (SIC) in patients under investigation for occupational asthma (OA). Psychosomatic Medicine, 73: A8.

72. Bacon SL, Wright A, Lavoie KL. (2011). Physical activity, body mass index, exercise, and asthma. Psychosomatic

Medicine, 73: A8-9. 73. Bacon SL, Lavoie KL, Marsland AL, Morizio A, Ritz, T. (2011). Biobehavioral processes in asthma: Understanding

mechanisms, implementing interventions. Psychosomatic Medicine, 73: A8. 74. Ouellet, K., Boudreau, M., Plourde, A., Bacon, S.L., & Lavoie, K.L. Impact of cigarette smoking, anxiety, and depression

on asthma control. Psychosomatic Medicine 2011; 73(3): 99. 75. Rossi A, Lavoie KL, Arsenault A, Bacon SL. (2011). The impact of physical activity on major adverse cardiovascular

events (MACE). Psychosomatic Medicine, 73: A48. 76. Meloche B, Jolicoeur L, Arsenault A, Bacon SL, Lavoie KL. (2011). The effect of anxiety disorders and insuline

resistance on muscular hyperemic uptake. Psychosomatic Medicine, 73: A81.

Kim L. Lavoie Ph.D.

V June 2016

77. Jolicoeur L, Meloche B, Arsenault A, Lavoie KL, Bacon SL. (2011). Anxiety disorders and triglyceride/HDL ratio: an interactive effect on muscular hyperemic flow response. Psychosomatic Medicine, 73: A45.

78. Arsenault A, Meloche B, Jolicoeur L, Lavoie KL, Bacon SL. (2011). Interaction of anxiety disorders and insulin blood levels in the muscular metabolism of cardiac outpatients. Psychosomatic Medicine, 73: A45.

79. Plourde, A., Lavoie, K.L., Ring, C., Carroll, D., & Bacon, S.L. The association between depression and psychological

stress reactivity in coronary artery disease (CAD) patients. Psychosomatic Medicine 2011, 73(3), A-49. 80. Jacob, A., Bacon, S.L., Boudreau, M., Lavoie, K.L. The effect of depressive disorders on changes in body mass index

in adult patients with asthma. Psychosomatic Medicine 2011, 73 (3), A-100. 81. Evans JA, Lavoie KL, Bacon SL, Campbell TS. (2011). The effect of trait rumination on habituation to repeated stress.

Psychosomatic Medicine, 73: A54. 82. Moullec, G., Ninot, G., Pepin, V., Laurin, C., Rizk, A., Jacob, A., Lavoie, K.L. Ecological momentary assessment

(EMA) : A new way to evaluate psychological impact of pulmonary rehabilitation in COPD patients? Psychosomatic Medicine, 2011;73 (3), A-71.

83. Moullec, G., Laurin, C., Bacon, S., Lavoie, K.L. Do anxiety and depression increase the risk for exacerbation in patients

with COPD? A systematic review and a meta-analysis. Psychosomatic Medicine, 2011, 73(3), A71.

84. Jacob, A., Laurin, C., Boudreau, M., Lavoie, K.L., Bacon, S.L. Underweight COPD patients are at greater risk of inpatient treated exacerbations. Proceedings of the 17th Annual Meeting of the International Society for the Advancement of Respiratory Psychophysiology (ISARP). Biological Psychology, 2010; 87, (1), 176.

85. Ouellet, K., Bacon, S.L., & Lavoie, K.L. Is anxiety and depression associated with cigarette smoking in adult

asthmatics? Proceedings of the 17th Annual Meeting of the International Society for the Advancement of Respiratory Psychophysiology (ISARP), Biological Psychology 2010; 87:168-90.

86. Joseph, M., Bacon, S. L., Ditto, B., Favreau, H., & Lavoie, K. L. Depression in patients under investigation for

occupational asthma: Is there a relationship to lung function, and blood and sputum cell differentials? Proceedings of the 17th Annual Meeting of the International Society for the Advancement of Respiratory Psychophysiology (ISARP), Biological Psychology 2011; 87, 168-180.

87. Favreau H, Lavoie KL, Bacon SL, Labrecque M. Prognostic impact of panic disorder and panic-like anxiety on asthma control, health service use, and quality of life in adult asthma patients. Proceedings of the 17th Annual Meeting of the International Society for the Advancement of Respiratory Psychophysiology (ISARP), Biological Psychology 2010; 87:168-90.

88. Bouchard A, Bacon SL, Lavoie KL. Health behaviours and psychological characteristics of COPD and asthma patients

presenting to the emergency room for a acute exacerbation of their pulmonary disease: a descriptive study. Proceedings of the 17th Annual Meeting of the International Society for the Advancement of Respiratory Psychophysiology (ISARP), Biological Psychology 2010; 87:168-90.

89. Laurin C, Bacon SL, Labrecque M, Moullec G, Lavoie KL. Are psychiatric disorders associated with mortality in patients with chronic obstructive pulmonary disease? Proceedings of the 17th Annual Meeting of the International Society for the Advancement of Respiratory Psychophysiology (ISARP), Biological Psychology 2010; 87:168-90.

90. Boudreau M, Jacob-Lessard A, Bacon SL, Lavoie KL. The Relationship Between Generalized Anxiety Disorder and

Asthma Morbidity In Adult Asthmatics. Proceedings of the 17th Annual Meeting of the International Society for the Advancement of Respiratory Psychophysiology (ISARP), Biological Psychology 2010; 87:168-90.

Kim L. Lavoie Ph.D.

V June 2016

91. Lavoie KL. Laurin C, Labrecque M, Bacon SL. Differential impact of mood and anxiety disorders on risk for COPD exacerbations. Psychosom Med, 2010, A147.

92. Lavoie KL. Bouthillier D, Bacon SL, Lemiere C, Martin J, Hamid Q, Ludwig M, Olivenstein R, Ernst, P. Psychological distress and maladaptive coping styles in patients with severe versus moderate asthma. Psychosom Med, 2010, A146.

93. Bacon SL, Boudreau M, Jacob-Lessard A, Ouellet K, Lavoie KL. Association of physical activity and asthma control.

Association of physical activity and asthma control. Psychosom Med, 2010, A146. 94. Rossi A, Davies E, Lavoie KL, Gordon J, Arsenault A, Pelletier R, Bacon SL. The association of brachial flow and

metabolic syndrome with cardiovascular responses to physical stress. Psychosom Med, 2010, A137. 95. Jacob, A., Lavoie, K.L., Laurin, C., Labrecque, M., & Bacon, S.L. (2010). Impact of self-efficacy on risk for

exacerbations in chronic obstructive pulmonary disease (COPD) patients. Psychosom Med, 2010, A120.

96. Ouellet K, Boudreau M, Bacon SL, Lavoie KL, Psychosocial correlates of action plan use in moderate-severe asthmatics. Psychosom Med, 2010, A93.

97. Pelletier R, Bacon SL, Arsenault A, Lavoie KL, The impact of anxiety on false negative ECG diagnoses of myocardial

ischemia. Psychosom Med, 2010, A 131. 98. Boudreau M, Bacon SL, Ouellet K, Lavoie KL. Body Mass Index Is Associated With Severity of Depressive Symptoms

and Anxiety Sensitivity in Adult Asthmatics. Psychosom Med, 2010, A60. 99. Gordon J, Lavoie KL, Arsenault A, Ditto B, Bacon SL. The Effect of Anxiety Sensitivity on Post-Exercise Cardiovascular

Recovery in Men and Women. Psychosom Med, 2010, A106. 100. Zhao X, Lavoie KL, Bacon SL, Meloche B, Jolicoeur J, Arsenault A. Is C-reactive protein mediating uptake of myoview

in depressive patients according to sex. Psychosom Med, 2010, A139. 101. Meloche B, Zhao X, Lavoie KL, Bacon SL, Jolicoeur L, Arsenault A. The impact of sex and C-Reactive Protein levels on

endothelial function in cardiac outpatients. Psychosom Med, 2010, A139.

102. Jolicoeur L, Zhao X, Bacon, SL, Lavoie KL, Meloche M, Arsenault A. The impact of depressive disorders on resting blood pressure in men versus women undergoing exercise stress testing. Psychosom Med, 2010, A81.

103. Arsenault A, Zhao X, Meloche B, Jolicoeur L, Bacon SL, Lavoie KL. Interaction of sex and depressive disorders in the

vascular and metabolic reactivity of cardiac outpatients. Psychosom Med, 2010, A137. 104. Peláez S, Lavoie KL, Arsenault A, Bacon SL. (2010). Is social integration associated with exercise involvement in

coronary heart disease patients? Journal of Cardiopulmonary Rehabilitation and Prevention, 30: 352. 105. Pelland, M.-E., Lessard, M.-J., Marchand, A., Belleville, G., Poirier-Bisson, J., Crevier, M. G., Watts, S. & Lavoie, K.L.

(2010). Efficacy of paroxetine and brief cognitive behavior therapy for panic disorder in patients consulting the emergency room with a chief complaint of chest pain. Poster qui sera présenté World Congress of Behavioral

106. and Cognitive Therapies, 2-5 juin 2010, Boston, MA.

107. Lessard, M.-J., Pelland, M.-E., Marchand, A., Belleville, G., Poirier-Bisson, J., Favre, V., Leclerc, M., Lavoie, KL. (2010). Comparing a brief and a self-managed cognitive behavior therapy to usual care in patients consulting the emergency room for non-cardiac chest pain related to panic disorder. Présentation par affiche dans le cadre du World Congress of Behavioral and Cognitive Therapies, Boston, MA.

Kim L. Lavoie Ph.D.

V June 2016

108. Rossi A, Davies E, Gordon J, Lavoie KL, Arsenault A, Pelletier R, Bacon SL. (2009). The impact of metabolic syndrome and endothelial dysfunction on exercise-induced cardiovascular changes. Canadian Journal of Cardiology. 25 (suppl. B): 206B.

109. Gordon JL, Lavoie KL, Arsenault A, Ditto B, Bacon SL. (2009). Sex Differences in the Effect of Anxiety Sensitivity on

Post-Exercise Cardiovascular Recovery. Canadian Journal of Cardiology, 25 (suppl. B): 100-101B. 110. Barone S. Lavoie KL, Arsenault A, Bacon SL. (2009). The Effect of Menopausal Status and HRT use on the Metabolic

Syndrome. Canadian Journal of Cardiology, 25 (suppl. B): 99B. 111. Bacon SL, Tsai B, Gordon J, Laurin C, Favret S, Arsenault A, Lavoie KL. (2009). Association of gender identity and sex

with C-reactive protein levels in patients with hypertension. Canadian Journal of Cardiology, 25 (suppl. B): 103B. 112. Lavoie KL, Laurin C, Labrecque M, Bacon SL. (2009). The impact of psychiatric disorders on COPD exacerbations.

CHEST, 136. 113. Rizk A, Bacon SL, Chan-Thim E, Lavoie KL, De Lorimier M, Pepin V. (2009). Acute Affective and Physiological

Response to Exercise Training in Chronic Obstructive Pulmonary Disease: A Pilot Study. Chest, 136: 125S. 114. Bacon SL, Harvey M-S, Wright A, Lavoie KL. (2009). The relationship between smoking, body mass index, and level of

prescribed inhaled corticosteroids in asthma patients. Chest, 136: 49S. 115. Bacon SL, Laurin C, Labrecque M, Lavoie KL. (2009). Higher self-efficacy is associated with a reduction in chronic

obstructive pulmonary disease (COPD) exacerbations. Chest, 136: 51S.

116. Lacoste G, Bacon SL, Joseph M, Favreau H, Labrecque M, Lavoie KL. (2008). Prevalence of psychiatric disorders in patients undergoing specific challenge tests for the diagnosis of occupational asthma. Presented at the European Respiratory Society Annual Meeting Berlin, October 4-8, 2008 (www.ers-education.org).

117. Lavoie KL, Laurin C, Flores-Echaiz CA, Arsenault A, Bacon SL. The interaction of smoking volume and smoking

cessation on endothelial function in cardiac patients. Psychosomatic Medicine, 2009: 71:A119 118. Bacon SL, Laurin C, Arsenault A, Ditto B, Campbell TS, Lavoie KL. Anxiety disorders predict 1-year development of

hypertension. Psychosomatic Medicine, 2009: 71:A71 119. Boudreau M, Lavoie KL, Bacon SL. Relationship between anxiety sensitivity and asthma triggers. Psychosomatic

Medicine, 2009: 71:A50

120. Bekkouche NS, Lavoie KL, Arsenault A, Ditto B, Bacon SL. Trait symptom reporting and myocardial ischemia and pain perception in patients undergoing exercise stress testing. Psychosomatic Medicine,2009: 71: A133-A134

121. Pelletier R, Bacon SL, Arsenault A, Lavoie KL. Relationship between depression, cardiovascular disease, and patients

motivation for medication adherence. Psychosomatic Medicine, 2009:71:A60

122. Favret S, Lavoie KL, Arsenault A, Bacon SL. The impact of sex and metabolic syndrome on cardiovascular disease (CVD) progression. Psychosomatic Medicine, 2009:71: A35-A36

123. Boudreau M, Bacon SL, Lavoie KL. Persistence of psychiatric disorders in patients with asthma. Annals of Behavioral

Medicine, 2009: 37:S163 124. Laurin C, Lavoie KL, Arsenault A, Ditto B, Bacon SL. The impact of mood and anxiety disorders on the development of

high blood pressure. Canadian Journal of Cardiology. 2009,24:E179.

Kim L. Lavoie Ph.D.

V June 2016

125. Favret S, Laurin C, Lavoie KL, Arsenault A, Bacon SL. Sex differences in the relationship between metabolic syndrome and endothelial dysfunction. Annals of Behavioral Medicine, 2009: 37:S54

126. Laurin C, Flores-Echaiz CA, Lavoie KL, Arsenault A, Bacon SL.. The impact of smoking volume and length of cessation

on endothelial function. Canadian Journal of Cardiology. 2009,24:E179.

127. Peláez, S., Lavoie, K.L., Arsenault, A. & Bacon, S.L. (2008). Social Support and exercise in cardiac patients: A one year follow-up. Journal of Cardiopulmonary Rehabilitation and Prevention, 28(5): 343.

128. Bacon SL, Arsenault A, Stebenne P, Ditto B, Campbell TS, Lavoie KL. 2008. Impact of silent ischemia on 1 year major

cardiovascular events in patients undergoing SPECT exercise testing. Canadian Journal of Cardiology. 129. Samek, D., Lavoie, K. L., Joseph, M., Ditto, B., & Bacon, S. L. Does asthma self-efficacy predict adherence to daily

asthma controller medication? Canadian Respiratory Journal, 2008:15:39C 130. Favreau H, Bacon SL, Rizk A, Bouchard A, Joseph M, Piccioni M, Labrecque M, Lavoie KL. What factors are

associated with suicidal ideation In asthma patients? Canadian Respiratory Journal 2008, 15:36C

131. Laurin C, Labrecque M, Lavoie KL, Cartier A, Bacon SL. Les effets des trouble psychiatriques et du sexe sur les exacerbations chez les patients souffrant de maladie pulmonaire obstructive chronique. Canadian Respiratory Journal, 2008 : 15 :44C-45C

132. Piccioni M, Lavoie KL, Rizk A, Wright A, Bacon SL. Sex differences in the relationship between body fat distribution and

asthma control. Canadian Respiratory Journal, 2008: 15 :37C-38C 133. Rizk A, Pépin, V, Lavoie KL, Joseph M, Wright A, Favreau H, Bacon SL. (2008). Effects of inhaled corticosteroids on

weight gain among patients with asthma. Canadian Respiratory Journal, 15(Supp SC), 39C. 134. Wright A, Lavoie KL, Joseph M, Rizk A, Bacon SL. Effects of smoking on asthma quality of life. Canadian Respiratory

Journal, 15 :39C 135. Bouchard A, Bacon SL, Boisvert I, Loucks E, Lavoie KL. (2008). Is socio-economic status associated with worse

asthma in adults? Canadian Respiratory Journal, 15(Supp SC), 38C. 136. Pellletier R, Lavoie KL, Stébenne P, Gordon, J, Paelez S, Laurin C, Meloche B, Arsenault A, Bacon SL. (In press).

Relationship between inflammatory processes and depressive disorders. Canadian Psychology 2008, 49(2a) :145. 137. Bouchard A, Lavoie KL, Favreau H, Bacon SL. (2008). Influence de la sensibilité à l’anxiété sur la morbidité chez les

asthmatiques. Canadian Psychology, 49(2a): 134. 138. Favreau H, Lavoie KL, Bacon SL, Bouchard A, Joseph M, Labrecque M. Les asthmatiques atteints d’un trouble panique

ont-ils une moins bonne maîtrise de l’asthme et qualité de vie reliée à l’asthme à 1 an de suivi ? Canadian Psychology 2008: 49(2a) :137.

139. Gordon JL, Loucks EB, Lavoie KL, Ditto B, Arsenault A, Bacon SL. Health Behaviors Mediate the Relationship between

Depressive Symptoms and CVD and All-Cause Mortality: The Framingham Heart Offspring Study. Psychosomatic Medicine 2008; 70:A-103.

140. Pelletier R, Lavoie KL, Stebenne P, Gordon J, Pelaez S, Laurin C, Meloche B, Arsenault A, Bacon SL. Relationship

between inflammatory processes and depressive disorders. Psychosomatic Medicine 2008; 70: A-54.

Kim L. Lavoie Ph.D.

V June 2016

141. Bekkouche NS, Lavoie KL, Laurin C, Arsenault A, Ditto B, Bacon SL. The relationship between myocardial ischemia, chest pain, and menopausal status in women undergoing exercise stress testing. Psychosomatic Medicine 2008; 70:A-16.

142. Meloche B, Arsenault A, Jolicoeur L, Bekkouche NS, Laurin C, Lavoie KL, Ditto B, Stebenne P, Pelletier R, Gordon JL,

Pelaez S, Zhao X, Bacon SL. The effect of C-reactive protein and sedimentation on vascular and metabolic reactivity according to sex and metabolic syndrome status. Psychosomatic Medicine 2008; 70: A-77.

143. Jolicoeur L, Arsenault A, Meloche B, Bekkouche NS, Laurin C, Lavoie KL, Ditto B, Stebenne P, Pelletier R, Gordon JL,

Pelaez S, Zhao X, Bacon SL. Are There Sex Differences in the Relative Contribution of Classic Cardiac Risk Factors to the Metabolic Syndrome? Psychosomatic Medicine 2008; 70: A-76.

144. Lavoie KL, Bouchard A, Boisvert I, Loucks EB, Bacon SL. Do socially disadvantaged adults have worse asthma?

Psychosomatic Medicine 2008: 70: A-80. 145. Stebenne PR, Lavoie KL, Arsenault A, Laurin C, Pelaez S, Meloche B, Bacon SL. The association between positive

and negative affect and insulin resistance in patients undergoing exercise stress testing. Psychosomatic Medicine 2008:70: A-30.

146. Stebenne PR, Lavoie KL, Arsenault A, Laurin C, Pelaez S, Meloche B, Bacon SL. The association between Positive

and Negative Affects and lipids levels in patients with and without coronary artery disease (CAD). Psychosomatic Medicine 2008:70:A-32.

147. Bacon SL, Arsenault A, Lavoie KL. Impact of Leisure time physical activity on psychiatric disorders in patients

undergoing exercise stress testing. Psychosomatic Medicine 2008: 70:A-91. 148. Gordon JL, Lavoie KL, Arsenault A, Pelletier R, Stébenne P, Bekkouche N, Ditto B, Bacon SL. The Effect of Depression

on Cardiovascular Recovery After Exercise in Men and Women. Canadian Journal of Cardiology 2007; 23:C35. 149. Pelletier R, Lavoie KL, Arsenault A, Meloche B, Stebenne P, Gordon J, Bacon SL. Effects of mood disorders and

endothelial dysfunction on exercise induced blood pressure and heart rate changes. Canadian Journal of Cardiology 2007:23: 91C.

150. Bacon SL, Veldhuijzen van Zanten JJCS, Lavoie KL, Meloche B, Stebenne PR, Arsenault A. The impact of baseline endothelial function on brachial artery reactivity responses to acute psychological stress. Canadian Journal of Cardiology 2007, 23: 160C.

151. Bacon SL, Lavoie KL, Campbell TS, Arsenault A, Ditto B. Influence of resting and exercise-induced blood pressure on chest pain intensity and unpleasantness. Canadian Journal of Cardiology, 2007 :23 :35-36C.

152. Joseph M, Lavoie KL, Favreau H, Bouchard A, Ditto B, Bacon SL. (2007). What factors are associated with reports of stress-induced asthma? Canadian Psychology, 48(2a): 129.

153. Lavoie KL, Bacon SL, Labrecque M. (2007). What’s worse for asthma control: depression or anxiety? Canadian Psychology, 48(2a): 287.

154. Laurin C, Lavoie KL, Bacon SL, Labrecque M. (2007). The prevalence and impact of mood and anxiety disorders in chronic obstructive disease patients. Canadian Psychology, 48(2a): 287.

155. Pelletier R, Lavoie KL, Bacon SL, Arsenault A. (2007). Why do depressed cardiac patients die? Mechanisms linking depression to cardiac morbidity and mortality. Canadian Psychology, 48(2a): 287.

156. Bacon SL, Lavoie KL, Arsenault A. (2007). Depression as a risk factor for chronic disease: A review of established and novel mechanisms. Canadian Psychology, 48(2a): 287.

157. Bouchard A, Lavoie KL, Favreau H, Joseph M, Bacon SL. (2007). The association between asthma self-efficacy, asthma control and medication adherence. Canadian Psychology, 48(2a): 125.

Kim L. Lavoie Ph.D.

V June 2016

158. Stébenne P, Lavoie KL, Arsenault A, Ditto B, Campbell T, Bacon SL. (2007). Are chest pain and myocardial ischemia related to hypochondiasis and alexithymia in stable heart disease patients? Canadian Psychology, 48(2a): 113-114.

159. Favreau H, Lavoie KL, Bacon SL, Bouchard A, Joseph M, Piccioni M, Labrecque M. (2007). The effects of panic disorder on suicidal ideation in asthma patients, is it the most important anxious disease? Canadian Psychology, 48(2a): 126.

160. Gordon JL, Lavoie KL, Arsenault A, Pelletier R, Stebenne P, Ditto B, Bacon SL. (2007). The effects of depression on cardiovascular recovery after exercise in men and women. Psychosomatic Medicine, 69: A48.

161. Zhao X, Arsenault A, Lavoie KL, Meloche B, Bacon SL. Model Simulation of Forearm Hyperaemic Reactivity. Accepted for the Canadian Medical and Biological Engineering Conference Toronto, June 16-19, 2007.

162. Lavoie KL, Bacon SL, Pelletier R, Stébenne PS, Gordon J, Meloche B, Veldhuijzen van Zanten, J.,Arsenault A. The differential impact of depressive and anxiety disorders on a novel measure of endothelial function. Psychosomatic Medicine 2007, 69:A50.

163. Gordon J, Lavoie KL, Arsenault A, Pelletier R, Stébenne PR, Ditto B, Bacon SL. The effects of depression on cardiovascular recovery after exercise in men and women. Psychosomatic Medicine 2007, 69:A48.

164. Arsenault A, Lavoie KL, Dupuis J, Meloche B, Veldhuijzen van Zanten, J., Pelletier R, Stébenne PR, Gordon J, Bacon SL. Sex differences in endothelial dysfunction (ED) and the metabolic syndrome. Psychosomatic Medicine 2007, 69:A80.

165. Meloche B, Bacon SL, Lavoie KL, Pelletier R, Stébenne PR, Gordon J, Arsenault A. Psychiatric disorders, psychological distress and the metabolic syndrome. Psychosomatic Medicine 2007, 69:A82.

166. Laurin C, Lavoie KL, Bacon SL, Dupuis G, Labrecque M. Psychiatric disorders and psychological distress in chronic obstructive pulmonary disease patients. Psychosomatic Medicine 2007, 69:A51.

167. Laurin C, Lavoie KL, Arsenault A, Bacon SL. Hormonal replacement therapy (HRT) and psychiatric disorders: the association with ischemia. Psychosomatic Medicine 2007, 69: A-51.

168. Veldhuijzen van Zanten, J, Arsenault A, Lavoie KL, Meloche B, Stébenne P, Bacon SL. Endothelial function and stress-induced ischemia. Psychosomatic Medicine 2007,69: A27.

169. Bacon SL, Veldhuijzen van Zanten, J, Lavoie KL, Meloche B, Stébenne PR, Arsenault A. Mental stress-induced endothelial function changes: the role of catecholamines. Psychosomatic Medicine 2007, 69:A100.

170. Joseph M, Bouchard A, Favreau H, Ditto B, Bacon SL, Lavoie KL. The association between asthma self-efficacy, psychiatric disorders, and stress-induced asthma. Psychosomatic Medicine 2007, 69:A-53.

171. Favreau H, Lavoie KL, Joseph M, Julien M, Labrecque M. Case-control trial of a multidisciplinary behavior intervention for health service use in patients with COPD. Psychosomatic Medicine 2007, 69:A54.

172. Stébenne PR, Lavoie KL, Pelletier R, Gordon J, Pelaez S, Laurin C, Meloche B, Arsenault A, Bacon SL. The influence of positive and negative affect on ischemia and chest pain. Psychosomatic Medicine 2007, 69:A-70.

173. Favreau H, Bouchard A, Joseph M, Piccioni M, Bacon SL, Labrecque M, Lavoie KL. What factors are associated with suicidal ideation in asthma patients? Psychosomatic Medicine 2007, 69:A54.

174. Bouchard A, Favreau H, Joseph M, Bacon SL, Laurin C, Piccioni M, Lavoie KL. The association between psychiatric disorders, psychological distress and asthma self-efficacy. Psychosomatic Medicine 2007, 69:A53-54.

175. Piccioni M, Lavoie KL, Bouchard A, Favreau H, Bacon SL. Effects of central and total fat on asthma morbidity. Psychosomatic Medicine 2007, 69:A54.

176. Favreau H, Lavoie KL, Julien M, Labrecque M. Implantation d’un programme de soins integers pour les patients MPOC et effect sur l’utilisation des services de santé. Canadian Respiratory Journal 2007;14 :40.

177. Piccioni M, Lavoie KL, Bouchard A, Favreau H, Bacon SL. Effects of central and total body fat on asthma morbidity. Canadian Respiratory Journal 2007: 14: 41-42

Kim L. Lavoie Ph.D.

V June 2016

178. Bouchard A, Favreau H, Piccione M, Labrecque M, Bacon SL, Lavoie KL. Comment parvenir à un contrôle optimale de l’asthme? L’influence du sentiment d’auto éfficacité. Canadian Respiratory Journal 2007;14 :46.

179. Laurin C, Lavoie KL, Bacon SL, Bouchard A, Dupuis G, Cartier A, Labrecque M. Les troubles psychiatriques et le taux d’exacerbations aigues chez les patients souffrant de MPOC. Canadian Respiratory Journal 2007;14 :51.

180. Arsenault, A., Meloche, B., Lavoie, K.L., Dupuis, J., Bacon, S.L. Relationship between brachial hyperaemic reactivity and the components of the metabolic syndrome in patients with and without cardiovascular disease. Canadian Journal of Cardiology 2006 :22 :85D.

181. Meloche, B., Bacon, S.L., Lavoie, KL., Dupuis, J., Arsenault, A. Characterising the kinetics of Myoview® time activity curves during brachial hyperaemia in patients with and without coronary artery disease. Canadian Journal of Cardiology 2006 :22:88D.

182. Gordon, J., Arsenault, A., Lavoie, K.L., Ditto, B., Meloche, B., Stébenne, P., Pelletier, R., Campbell, T.S., Bacon, S.L. The Effects of Smoking, Obesity, Alcohol Consumption and Physical Activity on Endothelial Function. Psychophysiololgy 2006; 43:S42.

183. Arsenault, A., Bacon, S.L., Lavoie, K.L., Meloche, B., Dupuis, J. Predicting ischemia in CAD patients from the brachial hyperaemic reactivity (BHR) curves. Journal of Nuclear Cardiology 2006, 13:S10.

184. Meloche, B., Bacon, S.L., Lavoie, K.L., Stébenne, P., Veldhuijzen van Zanten, J., Arsenault, A. Short term versus day-to-day reproducibility of scintigraphic brachial hyperaemic reactivity (SBHR): A new marker of endothelial function (EF). Journal of Nuclear Cardiology 2006, 13:S10.

185. Lavoie KL*, Bacon SL, Ditto, B. Pelletier R, Stébenne, PR, Meloche B, Arsenault A. Endothelial function in patients in patients with mood and anxiety disorders. Experimental and Clinical Cardiology, 2006 11: 32. CIHR Young Investigators Forum, Winnipeg, MA, May 2006. *FRSQ Travel Award

186. Lavoie KL, Bacon SL, Joseph M, Favreau H, Campbell TS, Labrecque M. The role of asthma self-efficacy in the achievement of optimal levels of asthma control. Canadian Respiratory Journal , 2006: 13: 156. CIHR Young Investigators Forum, Winnipeg, MA, May 2006.

187. Bacon, SL*, Lavoie KL, Meloche B, Arsenault A. Endothelial function and components of the metabolic syndrome as predictors of cardiovascular disease. Experimental and Clinical Cardiology 2006: A11:33. CIHR Young Investigators Forum, Winnipeg, MA, May 2006. *CIHR Travel Award & Best Poster Award

188. Meloche B, Bacon SL, Lavoie KL, Stébenne S, Veldhuizen van Zanten J. Scintigraphic Brachial Hyperhemic Reactivity (SBHR) in coronary artery disease patients (CAD) versus low risk controls (LRC): short term versus day-to-day reproducibility of a new marker of endothelial function (EF). Canadian Society of Nuclear Medicine (CSNM-AMSMNQ) Annual Meeting, Quebec City, Quebec, April 2006.

189. Pelland, M.-E., Lessard, M.-J., Marchand, A., Lavoie, K., Foldes-Busque, G. & Fleet, R. (2006) Traitement pharmacologique du trouble panique dans les services médicaux de première ligne. Présentation par affiche au 74e congrès de l'ACFAS, Montréal, Québec.

190. Lessard, M.-J., Pelland, M.-E., Marchand, A., Lavoie, K., Foldes-Busque, G., Fleet, R. (2006). Traitement du trouble panique chez les individus consultant les services d’urgence pour des douleurs thoraciques non-cardiaques. Présentation d’affiches au 74e Congrès de l’ACFAS, Montréal, Québec.

191. Lavoie KL, Joseph M, Favreau H, Labrecque M, Ditto B, Bacon SL. Prevalence of anxiety and mood disorders in patients under investigation for occupational asthma: A case of mistaken identity? Depress Anxiety 2007;24(4):293.

192. Lavoie KL, Bacon SL, Pelletier R, Stébenne PR, Meloche B, Arsenault A, Ditto B. Endothelial function in patients referred for myocardial perfusion imaging: The impact of anxiety and mood disorders. Journal of Anxiety Disorders; Anxiety Disorders Association of America Meeting, Miami, FL, March 2006.

193. Lavoie KL, Bacon SL, Stébenne PR, Pelletier R, Veldhuizen van Zanten J, Barone S, Meloche B, Arsenault A. Associations between mood and anxiety disorders and endothelial function in patients referred for myocardial perfusion exercise stress testing: A pilot study. Psychosomatic Medicine 2006; 68:A53. American Psychosomatic Society meeting, Denver, CO, March 2006.

Kim L. Lavoie Ph.D.

V June 2016

194. Lavoie KL, Joseph M, Favreau H, Campbell TS, Labrecque M, Bacon SL. The challenge of achieving optimal levels of asthma control: the impact of asthma self-efficacy. Psychosomatic Medicine 2006; 68:A88. American Psychosomatic Society meeting, Denver, CO, March 2006.

195. Arsenault A, Lavoie KL, Meloche B, Stébenne PR, Veldhuizen van Zanten J, Bacon SL. Comparison of endothelial function and the components of the metabolic syndrome in the prediction of coronary artery disease. Psychosomatic Medicine 2006; 68:A71-72. American Psychosomatic Society meeting, Denver, CO, March 2006.

196. Favreau H, Lavoie KL, Rahbi K, Labrecque M. Effectiveness of a behavioral self-management intervention to improve health-related quality of life in patients with chronic obstructive pulmonary disease. Psychosomatic Medicine 2006; 68:A90. American Psychosomatic Society meeting, Denver, CO, March 2006.

197. Barone S*, Bacon SL, Labrecque M, Favreau H, Ditto M, Lavoie KL. The association between atopy and anxiety sensitivity in adult asthma patients. Psychosomatic Medicine 2006; 68: A107-108. American Psychosomatic Society meeting, Denver, CO, March 2006. *Student Travel Award.

198. Meloche B, Bacon SL, Lavoie KL, Stébenne PR, Veldhuizen van Zanten J, Arsenault A. Differential exhaustion of repeated hyperemic reactivity in cardiac patients and normal controls. Psychosomatic Medicine 2006; 68:A73-74. American Psychosomatic Society meeting, Denver, CO, March 2006.

199. Veldhuizen van Zanten J*, Meloche B, Bacon SL, Stébenne PR, Arsenault A, Lavoie KL. Inter-observer reliability of a new method to measure endothelial function. Psychosomatic Medicine 2006; 68:A36. American Psychosomatic Society meeting, Denver, CO, March 2006. *Citation Poster Award.

200. Joseph M, Bacon SL, Favreau H, Labrecque M, Malo JL, Ditto B, Lavoie KL. The impact of job stress in patients under investigation for occupational asthma. Psychosomatic Medicine 2006; 68:A91-92. American Psychosomatic Society meeting, Denver, CO, March 2006.

201. Pelletier R, Bacon SL, Stébenne PR, Arsenault A, Meloche B, Fleet RP, Lavoie KL. The impact of anxiety disorders on exercise stress test performance: are they as important as depression? Psychosomatic Medicine 2006; 68:A53-54. American Psychosomatic Society meeting, Denver, CO, March 2006.

202. Stébenne P, Bacon SL, Pelletier R, Arsenault A, Meloche B, Fleet RP, Lavoie KL. Sex differences in the prevalence of psychiatric disorders in 2262 patients referred for nuclear stress testing. Psychosomatic Medicine 2006; 68:A53; American Psychosomatic Society meeting, Denver, CO, March 2006.

203. Lavoie, K.L., Bacon, S.L., Meloche, B., Fleet, R., Arsenault, A. Psychiatric morbidity in relation to ischemia and chest pain in patients undergoing exercise stress testing. Canadian Journal of Cardiology 2005; 21: 242C.

204. Bacon, S.L*, Lavoie, K.L., Campbell, T.S., Arsenault, A., Fleet, R., Ditto, B. The role of ischemia and pain in the blood pressure response of patients undergoing exercise stress testing. Canadian Journal of Cardiology 2005; 21: 66C. *Young Investigator Award: CCS

205. Bacon, S.L., Arsenault, A., Meloche, B., Lavoie, K.L., Grégoire, J., Dupuis, J. Comparison of endothelial function and the components of the metabolic syndrome in the prediction of coronary artery disease. Canadian Journal of Cardiology 2005; 21: 171C.

206. Laurin, C.*, Lavoie, KL., Bacon, S., Cartier, A., , Stébenne, P., Dupuis, G. & Labrecque, M. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with chronic obstructive pulmonary disease in a Canadian sample. CHEST, 2005 (in press). *Best Poster Award (1st prize): Airways Category

207. Lavoie KL, Bacon SL, Cartier A, Labrecque M, Lacoste G, Ditto B. Body mass index is associated with worse asthma control and quality of life among adult asthma patients. American Journal of Respiratory Critical Care Medicine 2005; 2:A589.

208. Lavoie KL*, Bacon SL, Cartier A, Labrecque M, Lacoste G, Barone S, Ditto B. The relative impact of mood and anxiety disorders on asthma control and quality of life. American Journal of Respiratory Critical Care Medicine 2005; 2:A519. *American Thoracic Society Travel Award

209. Laurin C, Lavoie KL, Labrecque M, Dupuis G, Cartier A. Prevalence of DSM-IV psychiatric disorders in a Canadian sample of COPD patients. American Journal of Respiratory Critical Care Medicine 2005; 2:A640.

Kim L. Lavoie Ph.D.

V June 2016

210. Lavoie KL, Bacon SL, Cartier A, Labrecque M, Lacoste G, Ditto B. Body mass index is associated with worse asthma control and quality of life among adult asthma patients. Canadian Respiratory Journal, 2005; 12:158

211. Lavoie KL, Bacon SL, Cartier A, Labrecque M, Lacoste G, Barone S, Ditto B. The relative impact of mood and anxiety disorders on asthma control and quality of life. Canadian Respiratory Journal: 2005; 12:158 *FRSQ Travel Award

212. Lavoie KL, Bacon SL, Fleet R, Ditto B, Arsenault A. Ischemia, chest pain and psychiatric morbidity in patients referred for exercise stress testing. Psychosomatic Medicine, 2005; 67:A92

213. Lavoie KL, Bacon SL, Cartier A, Labrecque M, Lacoste G, Barone S, Ditto B. What’s worse for asthma control and quality of life: Depression, anxiety or both? Psychosomatic Medicine, 2005; 67:A49

214. Lavoie KL, Bacon SL, Cartier A, Labrecque M, Lacoste G, Ditto B. Body mass index is associated with worse asthma control and quality of life among adult asthma patients. Psychosomatic Medicine 2005; 67:A49

215. Bacon SL, Lavoie KL, Ditto B, Arsenault A. Ischemia, pain and blood pressure response to exercise testing. Psychosomatic Medicine, 2005; 67:A57

216. Bacon SL, Lavoie KL, Fleet R, Meloche B, Arsenault A. Profile of gender differences in patients undergoing exercise stress testing : Why aren’t women ischemic? Psychosomatic Medicine, 2005; 67:A57

217. Arsenault A, Bacon SL, Lavoie KL, Meloche B. RUR and EWRU, new markers of endothelial dysfunction. Psychosomatic Medicine, 2005; 67:A38

218. Meloche B, Arsenault A, Lavoie KL, Bacon SL. Test-retest reliability of a new method to measure endothelial dysfunction. Psychosomatic Medicine, 2005; 67:A54

219. Lavoie KL, Cartier A, Labrecque M, Verrier P, Bacon SL, Ditto B. Prevalence of mood and anxiety disorders in asthmatics: impact on asthma adjustment and pulmonary function. American Journal of Respiratory Critical Care Medicine 2004; 169 (7): A261.

220. Lavoie KL, Cartier A, Labrecque M, Verrier P, Bacon SL, Ditto B. Prevalence of mood and anxiety disorders in asthmatics: impact on asthma control and quality of life. Canadian Respiratory Journal 2004; 11:243.*CIHR Student Travel Award

221. Lavoie KL, Cartier A, Labrecque M, Lacoste G, Verrier P, Ditto B, Bacon SL. Prevalence of mood and anxiety disorders among asthmatic outpatients: psychological profile and relation to pulmonary function. Psychosomatic Medicine 2004; 66:A-84.

222. Lavoie KL, Fleet RP, Arsenault A, Lesperance F, Frasure-Smith N, Laurin C, Bacon SL. Are electrocardiographic assessments of myocardial ischemia appropriate in depressed patients? Psychosomatic Medicine 2004; 66:A-53.

223. Neumark E, Miller S, Lavoie K, Young SN, Pihl R, Ditto B, Campbell T, Benkelfat C. Acute tryptophan depletion may modulate the relation between anger and cardiovascular reactivity. Psychosomatic Medicine 2004; 66:A-71.

224. Lavoie KL, Cartier A, Labrecque M, Verrier P, Bacon SL, Ditto B. Prevalence of anxiety disorders in asthmatics: impact on asthma adjustment and pulmonary function. Anxiety Disorders Association of America 2004; 76.

225. Lavoie KL, Laurin C, Fleet RP, Arsenault A., Miller SB. Is anxiety bad for your heart? The relationship between anxiety sensitivity and reduced heart rate variability in coronary artery disease patients. J Psychosom Res 2003; 55: 136.

226. Lavoie, KL, Laurin, C, Fleet RP, Arsenault, A., Miller SB. Heart rate variability in coronary artery disease patients with and without panic disorder. Psychosomatic Medicine 2003; 65:A-54.

227. Neumark E, Miller SB, Young SN, Pihl RO, Ditto B, Campbell T, Lavoie K, Sugden N, & Benkelfat C. Mood and cardiovascular response to stress: Effects of tryptophan depletion. Poster presented at the annual meeting of the Canadian College of Neuropsychopharmacology, Montreal, Quebec, 2003.

228. Neumark E, Miller SB, Young SN, Pihl RO, Ditto B, Campbell T, Lavoie K, Deria S, & Benkelfat C. Mood and cardiovascular response during anticipatory and stressor periods: Effects of acute tryptophan depletion. Poster presented at the annual meeting of the Society of Behavioral Medicine, Salt Lake City, Utah. March, 2003.

Kim L. Lavoie Ph.D.

V June 2016

229. Lavoie KL*, Fleet RP, Laurin C, Arsenault A, Burelle D, Miller SB. Anxiety sensitivity is associated with reduced heart rate variability in coronary artery disease patients. Psychosomatic Medicine 2002; 64:136. *Scholar Award

230. Lavoie KL, Fleet RP, Laurin C, Arsenault A, Burelle D, Miller SB. Myocardial ischemia and chest pain during daily life in coronary artery disease patient: A preliminary report. Psychosomatic Medicine 2002;64:136.

231. Fleet RP, Lespérance F, Lafontaine S, Arsenault A, Frasure-Smith N, Lavoie KL, Laurin C, Burelle D, Gregoire J, Harel F. Paroxetine treatment of panic disorder in patients with coronary artery disease : Improved emotional and myocardial response to 35% CO2-65% O2 panic challenge. Psychosomatic Medicine 2002;64:136.

232. Laurin C, Fleet RP, Lavoie KL, Arsenault A, Burelle D. Generalized anxiety disorder in coronary artery disease patients referred for exercise stress tests: Prevalence, psychiatric co-morbidity, and risk factor profile. Psychosomatic Medicine 2002;64:136.

233. Neumark E, Miller SB, Young SN, Lavoie KL, Campbell T, Ditto B, Pihl RO, Benkelfat C. Serotonin modulates the cardiovascular response to interpersonal conflict. Psychosomatic Medicine 2002; 64:136.

234. Lavoie KL, Fleet RP, Lesperance F, Arsenault A, Laurin C, Frasure-Smith N, Burelle D. Are exercise stress tests appropriate for assessing myocardial ischemia in patients with major depressive disorder? Psychosomatic Medicine 2001;63:91-190. *Citation poster

235. Lavoie KL, Fleet RP, Laurin C, Arsenault A, Lesperance F, Frasure-Smith N, Burelle D. Relationship between psychological factors and history of myocardial infarction in patients with exercise-induced ischemia. Psychosomatic Medicine 2001; 63:91-190.

236. Laurin C, Lavoie KL, Fleet RP, Arsenault A, Lesperance F, Frasure-Smith N, Burelle D. Suicidal ideation in patients with exercise-induced ischemia: Relationship to PRIME-MD diagnoses and psychological factors. Psychosomatic Medicine 2001; 63:91-190.

237. Fleet RP, Arsenault A, Lesperance F, Frasure-Smith N, Burelle D, Lambert J, Gregoire J, Lavoie KL, Laurin C, Beitman BD. Panic disorder is associated with reversible myocardial perfusion defects during panic challenge with 35% CO2. Psychosomatic Medicine 2001; 63:91-190.

238. Fleet RP, Arsenault A, Lesperance F, Frasure-Smith N, Burelle D, Lavoie KL, Laurin C, Beitman BD. PRIME-MD diagnoses in coronary artery disease patients referred for SPECT exercise stress tests. Psychosomatic Medicine 2001; 63:91-190.

239. Fleet RP, Arsenault A, Lesperance F, Frasure-Smith N, Burelle D, Lambert J, Gregoire J, Lavoie KL, Laurin C, Beitman BD. Reversible myocardial perfusion defects during panic challenge in coronary artery disease patients with and without panic disorder: Are panic attacks bad for your heart? Circulation 2000;102, suppl II: II-790.

240. Fleet RP, Arsenault A, Lesperance F, Frasure-Smith N, Burelle D, Lambert J, Gregoire J, Lavoie KL, Laurin C, Beitman BD. SPECT study of induced panic attacks in CAD patients with and without panic disorder: Are panic attacks bad for your heart? Canadian Journal of Cardiology 2000;16, Suppl. F: 202F.

241. Miller SB, Lavoie K, & Campbell T. Cardiovascular reactivity and perceived racism in Canadian black men and women. Paper presented at the 20th Annual Meeting of the Society of Behavioral Medicine, San Diego, CA, March 1999.

242. Fleet RP, Dupuis G, Marchand A, Lavoie K, & Beitman BD. Nonfearful panic disorder: A distinct subtype of panic in medical patients? Poster presented at the 57th Annual Meeting of the American Psychosomatic Society, Vancouver, BC, March 1999.

243. Miller SB, Lavoie K & Campbell T. Race, gender, racism, and cardiovascular reactivity in a Canadian population. Psychosomatic Medicine 2000; 62: 133.

PRESENTATIONS (KEYNOTES, PRESENTATIONS, WORSHOPS) International

Kim L. Lavoie Ph.D.

V June 2016

1. Lavoie, KL. Addressing psychosocial factors to improve treatment and outcomes in chronic respiratory disease. Invited Speaker. Breathing Conference, October 14-15, 2016, Tokyo, Japan.

2. Lavoie KL. Supporting behavior change and self-management in COPD patients: adapting the Living Well with COPD Program. Invited Speaker/Trainer. September 26-28, 2016, Mumbai, India (50 participants).

3. Lavoie KL. Providing emotional support for patients with Pulmonary Hypertension and their Caregivers. Invited speaker. 7th Bayer International PH Nurse Forum 2016, Sponsored by Bayer, September 15, 2016, Berlin, Germany (200 participants).

4. Lavoie KL. Designing more effective behavioral interventions that respect literacy and cultural diversity to improve chronic disease management. CHEST Annual Meeting Symposium, 26 October, 2015, Montreal, QC. (60 participants)

5. Lavoie KL. Why won’t they listen?! How motivational communication can improve adherence and outcomes in patients with chronic lung disease. European Respiratory Society Invited Symposium (sponsored by Boehringer Ingelheim), Amsterdam, The Netherlands, September 28, 2015 (300 participants).

6. Lavoie KL. Motivating people for change: How motivational communication skills can improve adherence and outcomes in patients with PH – Workshop. 6th Bayer International PH Nurse Forum 2015, Sponsored by Bayer, July 4, 2015, Riga, Latvia (50 participants).

7. Lavoie KL. Why won’t they listen?! How motivational communication skills can improve adherence and outcomes in patients with pulmonary hypertension. 6th Bayer International PH Nurse Forum 2015, Sponsored by Bayer, July 3, 2015, Riga, Latvia (200 participants).

8. Lavoie KL. Atelier : Pourquoi n’ecoutent-ils pas?! Comment la communication motivationnelle peut ameliorer l’observance et l’etat de sante des patients souffrant d’asthme. Les soignants viennent de Mars et les patients asthmatiques de Venus! Sponsored by Mundi Pharma, 21 juin, 2015, Paris, France (30 participants).

9. Lavoie KL. Pourquoi n’ecoutent-ils pas?! Comment les competences en communication motivationnelle peuvent ameliorer l’observance et l’etat de sante des patients souffrant d’asthme. Les soignants viennent de Mars et les patients asthmatiques de Venus! Sponsored by Mundi Pharma, 20 juin, 2015, Paris, France (250 participants).

10. Lavoie KL. Sloppy design, reporting and publishing: Why behavioral trials may be at risk of type II error and what we can do about it. iCEPS Conference, February 21, 2015, Montpellier, France (30 participants).

11. Lavoie, KL. Comment motiver les patients a changer: Principes et techniques de la communication motivationnelle. Clinique du Souffle Les Clarines, 17 fevrier, 2015, Riom-Es-Montagne, France (30 participants)

12. Lavoie KL, Bacon SL. Introduction to the International Behavioral Trials Network. International Congress of Behavioral Medicine, Groningen, The Netherlands, August 22, 2014.

13. Lavoie, KL, Ouellet I, Bourbeau J. Behavioral modification to increase physical activity among COPD patients. PHYSACTO Trial Site Training, Sponsored by Boehringer Ingelheim, Boston, MA, June 22, 2014 (25 participants)

14. Lavoie, KL. Motivating patients for behaviour change: Principles and techniques to optimize long-term change. PHYSACTO Trial Site Training, Sponsored by Boehringer Ingelheim, Boston, MA, June 22, 2014 (25 participants)

15. Lavoie KL. Impact of psychological and behavioral factors in asthma: A consolidation of findings from the Psychological factors in Asthma (PAL) Study, American Psychosomatic Society, San Francisco, CA, March 13, 2014 (25 participants).

16. Lavoie, KL, Sedeno M, Bourbeau J. Behavioral modification to increase physical activity among COPD patients. PHYSACTO Trial Site Training, Sponsored by Boehringer Ingelheim, Vienna, Austria, January 29, 2014 (90 participants)

17. Lavoie, KL. Motivating patients for behaviour change: Principles and techniques to optimize long-term change. PHYSACTO Trial Site Training, Sponsored by Boehringer Ingelheim, Vienna, Austria, January 28, 2014 (120 participants)

18. Lavoie KL. Prospective impact of mood and anxiety disorders on 5-year asthma control and health service use. Paper presented a the Annual Meeting of the American Psychosomatic Society, March 2013, Miami, FL.

19. Lavoie KL. Impact of depression and anxiety on cardiovascular disease: Acute and chronic stress effects on ischemic, inflammatory, and behavioural factors. Faculty of Medicine, Research Rounds, University of California – San Diego, San Diego, CA, March 6, 2013. (40 participants)

20. Lavoie KL. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, non-adherent asthmatics: Results from a randomized controlled pilot study. Paper presented at the Annual Meeting of the American College of Chest Physicians, October 2011, Honolulu, HI.

Kim L. Lavoie Ph.D.

V June 2016

21. Lavoie KL. The efficacy of brief motivational interviewing to improve medication adherence in poorly controlled, non-adherent asthmatics: The Asthma Control Trial (ACT). Paper presented at the Annual Meeting of the American Psychosomatic Society, March 2011, San Antonio, TX.

22. Lavoie KL. Prevention santé: des modeles theorique a la pratique. Plenary Invited Address, Colloque Internationale: Les reponses des sciences humaines aux enjeux de la santé, ICEPS conference, Montpellier, France, 25 mars, 2011. (400 participants)

23. Lavoie KL. Introduction a l’entretien motivationnelle. Grand Rounds, Clinique Medicale de Lodege, Lodege, France, 24 mars, 2011. (25 participants)

24. Lavoie KL. Asthma, hyperventilation and panic: how to tell them apart. Annual meeting of the American Academy of Asthma, Allergy and Immunology, New Orleans, LA, March 2, 2010. (25 participants)

25. Lavoie KL. Differential impact of mood and anxiety disorders on risk for COPD exacerbations. Paper presented at the Annual Meeting of the American Psychosomatic Society, March 2010, Portland, OR.

26. Lavoie KL. Motivational Interviewing for Lifestyle Change Workshop, Air Liquide Sante International, Paris, France, December 16, 2009. (30 participants)

27. Lavoie KL. Stress and COPD, American College of Chest Physicians Annual Meeting, San Diego, CA, November 3, 2009. (50 participants)

28. Lavoie KL. Asthma, hyperventilation and panic: how to tell them apart. Annual meeting of the American Academy of Asthma, Allergy and Immunology, Miami FL, March 15, 2009. (25 participants)

29. Lavoie KL. The interaction of smoking volume and smoking cessation on endothelial function in cardiac patients. Paper presented at the Annual Meeting of the American Psychosomatic Society, March 2009, Chicago, IL.

30. Lavoie KL. How to Change Patient Behaviour in 10 minutes or less? Canadian Cardiovascular Society Workshop, Vancouver, BC, October 24, 2006. (300 participants)

31. Lavoie KL. The relative impact of mood and anxiety disorders on asthma control and quality of life. Paper presented at the Annual Meeting of the American Thoracic Society, May 2005; San Diego, CA.

32. Lavoie KL. Prevalence of mood and anxiety disorders in asthmatics: impact on asthma adjustment and pulmonary function. Paper presented at the Annual Meeting of the American Thoracic Society, May 2004, Orlando, FL.

33. Lavoie KL Is anxiety bad for your heart? The relationship between anxiety sensitivity and reduced heart rate variability in coronary artery disease patients. Paper presented at the International Congress of Behavioral Medicine, August 2003, Waikoloa, HI.

34. Lavoie KL. Anxiety sensitivity is associated with reduced heart rate variability in coronary artery disease patients. Paper presented at the Annual Meeting of the American Psychosomatic Society, March 2002, Barcelona, Spain.

National 35. Lavoie KL, Gooderham MJ, Bacon SL, Campbell TS, Vallis M, Laurin C, Dragomir, A, Papp K. Clinician training in

motivational communication skills: The impact of Derm Connect Canada (Phase 1). Speaker, Canadian Dermatology Association Annual Meeting, June 25, 2016, Saskatoon, SK. (100 participants).

36. Lavoie KL. Can stress really kill you?! Canadian Association of Emergency Physicians Annual Meeting, Invited Symposium, June 6, 2016, Quebec City, QC (100 people).

37. Lavoie KL. Evidence-based stress management strategies for physicians. Canadian Association of Emergency Physicians Annual Meeting, Invited Symposium, June 6, 2016, Quebec City, QC (100 people).

38. Lavoie, KL. The Language of Change: Introduction to Motivational Communication to Optimize Outcomes in Patients with Chronic Inflammatory Arthritis (sponsored by Janssen). June 1, 2016, Brampton, ON (10 participants).

39. Lavoie KL. Why won’t they listen?! An introduction to motivational communication and to improve outcomes in cancer patients. Astellas Invited Workshop, May 26, 2016, Toronto, Ont (30 participants).

40. Lavoie KL. Why won’t they listen?! An introduction to motivational communication and how it can improve adherence and outcomes in patients undergoing cancer treatment. Canadian Association of Pharmacy in Oncology Annual Meeting, Plenary, April 16, 2016, Niagara Falls, Ont (300 participants).

41. Lavoie, KL. The Language of Change: Introduction to Motivational Communication to Optimize Outcomes in Patients with Chronic Inflammatory Arthritis (sponsored by Janssen). February 25, 2016, Thunder Bay, ON (15 participants).

Kim L. Lavoie Ph.D.

V June 2016

42. Lavoie KL. Supporting people living with inflammatory arthritis along their emotional journey. (National Program, sponsored by Abbvie). November 21, 2015, Montreal, QC (50 participants).

43. Lavoie KL. Why won’t they listen?! How motivational communication skills can improve adherence and patient outcomes in dermatology. Derm Academy (sponsored by Abbvie), November 7, 2015, Montreal QC (25 participants).

44. Lavoie KL. The Language of Change: Intermediate Workshop on Motivational Communication to Optimize Outcomes in Patients with Chronic Inflammatory Arthritis (sponsored by Janssen). September 15, 2015, Toronto, ONT (15 participants).

45. Lavoie KL. Why won't they listen? How motivational communication can improve adherence and outcomes in patients with cancer. OPTRA Group (oncology pharmacists), September 16, 2015, Toronto ONT (30 participants).

46. Lavoie KL. The Language of Change: Introduction to Motivational Communication to Optimize Outcomes in Patients with Chronic Inflammatory Arthritis (sponsored by Janssen). September 15, 2015, Toronto, ONT (10 participants).

47. Lavoie KL. Canadian Network for Health Behavior Change and Promotion (CAN-Change). Workshop – Canadian Psychological Association, June 3, 2015, Ottawa, ONT (30 participants).

48. Lavoie KL. Motivational Communication: A brief overview of its application to behavior change to improve outcomes in chronic disease. Workshop – Canadian Psychological Association, June 3, 2015, Ottawa, ONT (30 participants).

49. Lavoie KL. Why won’t they listen?! How motivational communication skills can improve adherence and patient outcomes. Renal Rounds, Regina General Hospital, May 29, 2015, Regina, SASK (60 participants).

50. Lavoie KL. How to engage patients and overcome resistance : Intermediate workshop on motivational communication. Dept. of Nephrology, Regina General Hospital, May 29, 2015, Regina, SASK (30 participants).

51. Lavoie KL. The Language of Change: Introduction to Motivtional Communication to Optimize Outcomes in Patients with Chronic Inflammatory Arthritis (sponsored by Janssen). May 20, 2015, Vancouver, BC (10 participants).

52. Lavoie KL. The Language of Change: Motivational Communication for Behaviour Change in Rheumatology, Canadian Rhematology Association (CRA) Annual Meeting, Plenary, February 6, 2015, Quebec City, QC (250 participants).

53. Lavoie KL. Motiviational communication for behaviour change in cardiac rehab. Canadian Association of Cardiovascular Prevention and Rehabilitation (CACPR), Webinar, January 21, 2015, Montreal, QC. (20 participants)

54. Lavoie KL & Bacon SL. The need for a behavioral science platform at CRRN. Canadian Respiratory Research Network (CRRN) Annual Meeting, January 16, 2015, Ottawa, ONT. (50 participants)

55. Lavoie KL & Bacon SL. Behavioral interventions for chronic lung disease: a focus on physical activity and adherence. Ottawa General Hospital Respirology Grand Rounds, Ottawa, ONT, January 5, 2015 (25 participants).

56. Lavoie KL. Motivational communication in the Dermatology Setting: Derm Connect Canada, Phase II Workshop. Sponsored by Abbvie, Canada, Markham, ONT, November 17, 2014. (10 participants)

57. Lavoie KL. Motivational communication in the Dermatology Setting: Derm Connect Phase 1 Workshop: Derm Update, Canadian Dermatology Nurses Association, Toronto, ONT, September 20, 2014. (60 participants)

58. Lavoie KL. Motivational communication in the Dermatology Setting: Derm Connect Nurses Canada, Phase I Workshop. Sponsored by Abbvie, Canada, Sudbury, ONT, August 26, 2014. (10 participants)

59. Lavoie KL. Using motivational communication to improve physical activity and health outcomes. Canadian Psychological Association Annual Meeting, Vancouver, BC, June 6, 2014 (60 participants).

60. Lavoie KL. Motivational communication in the Dermatology Setting: Derm Connect Canada, Phase I Workshop. Sponsored by Abbvie, Canada, Toronto, ONT, June 2, 2014. (12 participants)

61. Lavoie KL. Motivational communication in the Dermatology Setting: Derm Connect Canada – Nurses Program, Phase II Workshop. Sponsored by Abbvie, Canada, Toronto, ONT, May 8, 2014. (10 participants)

62. Lavoie KL. Motivational communication to improve adherence and outcomes in adults and children with chronic lung diseases. Invited Symposium Chair: Canadian Respiratory Conference, Calgary AB, April 24, 2014. (300 participants)

63. Lavoie KL. Introduction to motivational communication for behavior change in patients with chronic lung disease. Invited Talk: Canadian Respiratory Conference, Calgary AB, April 24, 2014. (300 participants)

Kim L. Lavoie Ph.D.

V June 2016

64. Lavoie KL. Prevalence and impact of depression and anxiety on COPD outcomes and quality of life. Invited Talk: Canadian Respiratory Conference, Calgary AB, April 25, 2014. (100 participants)

65. Lavoie KL. Motivational communication in the Dermatology Setting: Derm Connect Canada – Nurses Program, Phase I Workshop. Sponsored by Abbvie, Canada, Toronto, ONT, April 16, 2014. (15 participants)

66. Lavoie KL. Motivational communication in the Dermatology Setting: Derm Connect Canada Phase I & II Workshop. Sponsored by Abbvie, Canada, Toronto, QC, February 21, 2014. (10 participants)

67. Lavoie KL. Using motivational communication in your personal and professional life. Sponsored by Abbvie Canada, Toronto, ONT, December 2, 2013. (10 participants)

68. Lavoie KL. Rolling with Resistance: Motivating Your Patients to Take Control of Their Health. Hot Topics in Rhematology. Sponsored by Abbvie, Canada, Halifax, NS, October 4, 2013 (20 participants)

69. Lavoie KL. Waking Up to the Burden of Fatigue in Rheumatology Patients. Hot Topics in Rhematology. Sponsored by Abbvie, Canada, Halifax, NS, October 4, 2013 (20 participants)

70. Lavoie KL. Rolling with Resistance: Motivating Your Patients to Take Control of Their Health. Hot Topics in Rhematology. Sponsored by Abbvie, Canada, Toronto, Ont, September 28, 2013 (20 participants)

71. Lavoie KL. Rolling with Resistance: Motivating Your Patients to Take Control of Their Health. Hot Topics in Rhematology. Sponsored by Abbvie, Canada, Calgary, AB, September 21, 2013 (20 participants)

72. Lavoie KL. Waking Up to the Burden of Fatigue in Rheumatology Patients. Hot Topics in Rhematology. Sponsored by Abbvie, Canada, Calgary, AB, October 4, 2013 (20 participants)

73. Lavoie KL. Rolling with Resistance: Motivating Your Patients to Take Control of Their Health. Hot Topics in Rheumatology. Sponsored by Abbvie, Canada, BC, September 7, 2013 (20 participants)

74. Lavoie KL. Motivational interviewing in the Respiratory Setting: Advanced Workshop. Sponsored by Takeda, Canada, Calgary, AB, April 5, 2013. (30 participants)

75. Lavoie KL. Motivational interviewing in the Dermatology Setting: Why we need to consider a new approach to doctor-patient communication. Sponsored by Abbvie, Canada, Montreal, QC, March 23, 2013. (20 participants)

76. Lavoie KL. Motivational interviewing to promote lifestyle change: An introduction for General Practitioners. Sponsored by Takeda, Canada, Ottawa, ON, February 1, 2013. (20 participants)

77. Lavoie KL. Motivational interviewing to promote lifestyle change: An introductory Workshop. ASPIRE Train the Trainer Asthma Program (Takeda, Canada), Toronto, ON, January 12, 2013. (15 participants)

78. Lavoie KL. Motivational interviewing to promote lifestyle change: An introductory Workshop. ASPIRE Train the Trainer Asthma Program (Takeda, Canada), Toronto, ON, October 20, 2012. (20 participants)

79. Lavoie KL. Motivational interviewing to promote lifestyle change: An introductory Workshop. ASPIRE Train the Trainer Asthma Program (Takeda, Canada), Vancouver, BC, November 3, 2012. (20 participants)

80. Lavoie KL. An introduction to motivational interviewing to promote lifestyle change. Renal Grand Rounds, Regina Regional Hospital, Regina, Sask, April 27, 2012. (25 participants)

81. Lavoie KL. Motivational interviewing to promote lifestyle change: Intermediate Workshop. Renal Division Regina Regional Hospital, Regina, Sask, April 27, 2012 (15 participants)

82. Lavoie KL. Motivational interviewing to promote lifestyle change: An introductory Workshop. Heart and Stroke Foundation of Ontario Hypertension Collaborative, Toronto, Ont, March 30, 2012. (50 participants)

83. Lavoie KL. Motivational interviewing to promote lifestyle change: An Advanced Workshop. Heart and Stroke Foundation of Ontario Hypertension Collaborative, Toronto, Ont, March 30, 2012. (40 participants)

84. Lavoie KL. Motivational interviewing to promote lifestyle change: An introductory Workshop. Heart and Stroke Foundation of Ontario Hypertension Collaborative, Toronto, Ont, Dec 3, 2011. (150 participants)

85. Lavoie KL. Motivational interviewing to promote lifestyle change: An introductory Workshop. Heart and Stroke Foundation of Ontario Clinical Update, Toronto, Ont, Dec 8, 2011. (20 participants)

86. Lavoie KL. Motivational interviewing to promote lifestyle change: An advanced Workshop. Heart and Stroke Foundation of Ontario Clinical Update, Toronto, Ont, Dec 8, 2011. (20 participants)

87. Lavoie KL. Advanced Motivational Interviewing to promote lifestyle change: Workshop. Annual Meeting of the Canadian Association of Cardiac Rehabilitation (CACR), Vancouver, BC, October, 2011. (50 participants)

88. Lavoie KL. Motivational interviewing for to promote lifestyle change: An intermediate-advanced Workshop. Heart and Stroke Foundation of Ontario Hypertension Collaborative, Toronto, Ont., April 29, 2011. (25 participants)

89. Lavoie KL. Motivational interviewing to promote lifestyle change: An Introductory Workshop. Respiratory Rehabilitation Unit, University of Laval, Quebec City, Qc., April 8, 2011. (20 participants)

Kim L. Lavoie Ph.D.

V June 2016

90. Lavoie KL. Motivational interviewing for to promote lifestyle change: An intermediate-advanced Workshop. Heart and Stroke Foundation of Ontario Clinical Update, Toronto, Ont., December 9, 2010. (50 participants)

91. Lavoie KL. Motivational interviewing to promote lifestyle change: An introductory Workshop. Heart and Stroke Foundation of Ontario Clinical Update, Toronto, Ont., December 9, 2010. (100 participants)

92. Lavoie KL. An introduction to Motivational Interviewing to promote lifestyle change. Keynote. Annual Meeting of the Canadian Association of Cardiac Rehabilitation (CACR), Montreal, Qc, October, 2010. (100 participants)

93. Lavoie KL. Motivational interviewing for lifestyle change. Heart and Stroke Foundation of Ontario Clinical Update, Toronto, Ont., December 11, 2009. (100 participants)

94. Lavoie KL. An Introduction to Motivational Interviewing– Association of pharmacists, Edmonton, ALTA, September 25-26, 2009. (200 participants)

95. Lavoie KL. Motivational Interviewing for Lifestyle Change Workshop, Montreal Chest Hospital, Montreal, Qc, September 24, 2009. (20 participants)

96. Lavoie KL. Stress as a major global health burden: Implications for chronic disease prevention and treatment. Canadian Psychological Association Keynote Speaker, Young Investigator Award, Health Psychology, Montreal, Quebec, June 12, 2009. (300 participants)

97. Lavoie KL. Achieving Work-Life Balance, ICRH-CIHR Young Investigator’s Forum Workshop, Ottawa, Ont, May 2009. (75 participants)

98. Lavoie KL. Motivational interviewing to improve adherence to national hypertension guidelines: Half-day Workshop. Heart and Stroke Foundation of Ontario , Toronto , Ontario , April 25, 2009. (60 participants)

99. Lavoie KL. Motivational interviewing to improve adherence to national hypertension guidelines: Review of Case Studies. Heart and Stroke Foundation of Ontario, Toronto , Ontario , April 24, 2009. (35 participants)

100. Lavoie KL. How to motivate patients for lifestyle change. Canadian Association of Cardiac Rehabilitation Annual meeting, October 20, 2007, Quebec City, Qc, 2007. (150 participants)

101. Lavoie KL. Motivating patients for lifestyle change. Canadian Counsel of Cardiovascular Nursing Annual meeting, October 21, 2007, Quebec City, Qc, 2007. (150 participants)

102. Lavoie KL. Motivational interviewing to improve adherence to national hypertension guidelines. Heart and Stroke Foundation of Ontario, Toronto, Ontario, January 20, 2007. (200 participants)

103. Lavoie KL. Motivational interviewing to improve adherence to national hypertension guidelines. Heart and Stroke Foundation of Ontario, Toronto, Ontario, September 30, 2007. (200 participants)

104. Lavoie KL. The prevalence and impact of psychological stress and psychiatric disorders in patients referred for evaluation of occupational asthma: A case of mistaken identity? Safetynet Occupational Health and Safety Conference, St-John’s, NFLD, June 8, 2006. (150 participants)

105. Lavoie KL. Motivation interviewing for improving medication adherence. Workshop: Diabetes Conference, sponsored by Pfizer, Canada, Toronto, Ont: February 10, 2006. (350 participants)

106. Lavoie KL. Psychological and behavioral factors associated with achieving optimal levels of asthma control. Internal Medicine Grand Rounds, Scarborough Grace Hospital, Toronto, Ont, November 4, 2005. (50 participants)

107. Lavoie KL. Occupational Asthma. 2nd International Jack Pepys Workshop on Occupational Asthma. Toronto, Ontario, Canada, May 2004. (75 participants)

108. Lavoie KL. Anxiety and panic attacks: masqueraders of asthma. Workshop at the 6th Annual National Asthma and Education Conference (ASED-6), Montreal, Quebec, Canada, November 2003. (50 participants)

Provincial/Local 109. Lavoie KL. Le defis des maladies chroniques : La medecine comportementale et le besoin des psychologues de la

sante. Dept de psychologie, Colloque Annuelle, UQAM, 18 mars 2016 (50 participants). 110. Lavoie KL. The Language of Change: Intermediate Workshop on Motivational Communication to Optimize

Outcomes in Patients with Chronic Inflammatory Arthritis (sponsored by Janssen). February 11, 2016, Montreal Children’s Hospital, Montreal, QC (15 participants).

111. Lavoie KL. An introduction to motivational communication for sales reps. Novartis (Respiratory), January 21, 2016, Montreal, QC (50 participants).

112. Lavoie KL. Language of Change, Module 1 follow-up Webex (sponsored by Janssen), December 3, 2015, Montreal QC (10 participants).

Kim L. Lavoie Ph.D.

V June 2016

113. Lavoie KL. Motivating Patients to Change: Principles and Techniques of Motivational Communication Part 2 (follow-up Webex, sponsored by Abbvie), November 27, 2015, Montreal QC (20 participants).

114. Lavoie KL. Improving communication: Using motivational communication to promote better outcomes in rheumatological disorders (sponsored by Abbvie). November 21, 2015, Montreal, QC (50 participants).

115. Lavoie KL. Language of Change, Module 2 follow-up Webex (sponsored by Janssen), November 20, 2015, Montreal QC (10 participants).

116. Lavoie KL. Motivating Patients to Change: Principles and Techniques of Motivational Communication Part 1 (follow-up Webex, sponsored by Abbvie), November 18, 2015, Montreal QC (20 participants).

117. Lavoie KL. The Language of Change: Introduction to Motivational Communication to Optimize Outcomes in Patients with Chronic Inflammatory Arthritis (sponsored by Janssen). October 29, 2015, Montreal, QC (15 participants).

118. Lavoie KL. Language of Change, Module 1 follow-up Webex (sponsored by Janssen), October 7, 2015, Montreal QC (10 participants).

119. Lavoie KL. Motivating Patients to Change: Principles and Techniques of Motivational Communication (follow-up Webex, sponsored by Abbvie), September 11, 2015, Montreal QC (20 participants).

120. Lavoie KL. The Language of Change: Introduction to Motivational Communication to Optimize Outcomes in Patients with Chronic Inflammatory Arthritis (sponsored by Janssen). September 3, 2015, Quebec City, QC (10 participants).

121. Lavoie KL. Introduction to the Language of Change Program. Sponsored by Janssen, August 26, 2015, Montreal, QC. (30 participants).

122. Lavoie KL. Comment motiver les patients a changer: Principes et techniques de la communication motivationnelle. CHU Sainte Justine – Pediatric Rheumatology Conference (sponsored by Abbvie), May 15, 2015, Montreal, Quebec (40 participants).

123. Lavoie KL. Comment motiver les patients a changer: Principes et techniques de la communication motivationnelle. Rheumatology Nurses (sponsored by Abbvie), 1 avril 2015, Montreal, Quebec (25 participants).

124. Lavoie KL. An introduction to motivational communication in the context of cardiopulmonary rehab. Symposium on Cardiopulmonary Rehabilitiation, U of Laval, Plenary, February 20, 2015 (240 participants).

125. Lavoie KL. A stress researcher’s perspective on thriving (vs just surviving) your academic research career. FRQS COPD Network Annual Meeting, Plenary, Feburary 18, 2015, Quebec City, QC (90 participants).

126. Lavoie KL. An introduction to motivational communication for behavior change in rhematology. Janssen Pharmaceutical “Language of Change” Steering Committee meeting, January 23, 2015, Montreal, QC (12 participants).

127. Lavoie KL. Motivational communication to improve care among Hepatitic C patient. Sponsored by Abbvie, Canada, Montreal, QC, November 21, 2014. (20 participants)

128. Lavoie KL. Motivational communication in the Dermatology Setting: Derm Connect Canada, Phase II Workshop. Sponsored by Abbvie, Canada, Quebec City, QC, November 20, 2014. (10 participants)

129. Lavoie KL. Don’t sweat the small stuff: a stress researcher’s perspective on thriving vs just surviving your academic career. CQRS, November 6, 2014 (40 participants).

130. Lavoie KL. Introduction a la communication motivationnelle pour la gestion de l’hypertension. Hypertension Canada Annual Meeting, Gatineau, QC, October 17, 2014. (50 participants)

131. Lavoie KL. Behavioral modification to increase physical activity among COPD patients. Montreal CHEST Hospital, Montreal QC, October 15, 2014. (15 participants)

132. Lavoie KL. Introduction to motivational communication for health behavior change. Chronic Disease Division Seminar Series, Hopital du Sacre-Coeur de Montreal, October 2, 2104. (30 participants)

133. Lavoie KL. Motivational interviewing in the Dermatology Setting: Train-the-trainer for Dermatology Nurses. Sponsored by Abbvie, Canada, Montreal, QC, April 12, 2014. (20 participants)

134. Lavoie, KL, Sedeno M, Bourbeau J. Behavioral modification to increase physical activity among COPD patients. PHYSACTO Trial Site Training, Sponsored by Boehringer Ingelheim, Montreal, QC, April 3, 2014 (25 participants)

135. Lavoie, KL. Motivating patients for behaviour change: Principles and techniques to optimize long-term change. PHYSACTO Trial Site Training, Sponsored by Boehringer Ingelheim, Montreal, QC, April 4, 2014 (25 participants)

136. Lavoie KL. Motivating patients for behavior change in primary prevention. ACCELERATION National Training, Sponsored by Canadian Partnership Against Cancer (CPAC), Montreal, QC, March 20, 2014 (30 participants)

Kim L. Lavoie Ph.D.

V June 2016

137. Lavoie KL. Motivational interviewing in the Dermatology Setting: Train-the-trainer follow-up Webinar. Sponsored by Abbvie, Canada, Montreal, QC, February 17, 2014. (10 participants)

138. Lavoie KL. Motivational interviewing in the Dermatology Setting: Train-the-trainer follow-up Webinar. Sponsored by Abbvie, Canada, Montreal, QC, January 22, 2014. (10 participants)

139. Lavoie KL. Using motivational communication in your personal and professional life. Sponsored by Abbvie Canada, Montreal, QC, December 17, 2013. (10 participants)

140. Lavoie KL. Le Défi des Maladies Chroniques: La médecine comportementale et le besoin des psychologues de la santé (Plenary). Dept of Psychology Research Day, University of Montreal, Montreal, QC, April 18, 2013 (350 participants)

141. Lavoie KL. L’entretien motivationnelle: une nouvelle approche à la communication médicale. Symposium : Apprentissage et modifications comportementales:comment les favoriser. Universite de Laval, Quebec, QC, April 13, 2013 (120 participants)

142. Lavoie KL. Using motivational interviewing to improve communication in your personal and professional life. Kataka Medical Communication, Montreal, QC, November 26, 2012. (15 participants)

143. Lavoie KL. Motivational interviewing to promote lifestyle change: An introductory Workshop. ASPIRE Train the Trainer Asthma Program (Takeda, Canada), Montreal, QC, October 12, 2012. (20 participants)

144. Lavoie KL. An introduction to motivational interviewing to promote lifestyle change. Division of Respirology Grand Rounds, Jewish General Hospital, Montreal, Qc, Jan 19, 2012. (25 participants)

145. Lavoie KL. An introduction to motivational interviewing to promote lifestyle change. Division of Internal Medicine and Clinical Epidemiology Grand Rounds, McGill University Health Centre, Montreal, Qc, Nov 17, 2011. (30 participants)

146. Lavoie KL. Motivational interviewing to promote lifestyle change: An introductory Workshop. Heart and Stroke Foundation of Ontario Hypertension Collaborative, Toronto, Ont., April 29, 2011. (35 participants)

147. Lavoie KL. Motivational interviewing to promote lifestyle change: An Introductory Workshop. Family Medicine, University of Laval, Quebec City, Qc., April 8, 2011. (10 participants)

148. Lavoie KL. Introduction a l’entretien motivationnelle. Colloque : la motivation et la santé. Psychosomatic Medicine, Montreal, Quebec, March 18, 2011. (75 participants)

149. Lavoie KL. Behavioural Cardiology : Past, present and future. Axe de recherche en santé cardiovasculaire, Hopital du Sacre-Coeur de Montreal, February 11, 2011. (25 participants)

150. Lavoie KL. Optimizing asthma control: Impact of psychosocial and behavioural factors. Montreal Chest Hospital, Division of Epidemiology, Montreal, Quebec, November 4, 2010. (12 participants)

151. Lavoie KL. Psychological stress: Is it really that bad for your health? Family Medicine Grand Rounds, St. Mary’s Hospital Centre, June 3, 2010. (50 participants)

152. Lavoie KL. Impact of psychosocial factors on COPD. Reseau en santé respiratoire du FRSQ – Regroupement stratégique en MPOC – Feb. 11-12, Montreal, Qc, 2010. (100 participants)

153. Lavoie KL. How to change patient behavior in 10 minutes or less: An introduction to motivational interviewing. Family Medicine Grand Rounds, Jewish General Hospital, Montreal, Quebec, October 6, 2009. (50 participants)

154. Lavoie KL. Motivational interviewing for lifestyle change. Dept of Medicine, Hôpital Laval, April 7th, Ste-Foy, Qc, 2008. (Workshop). (75 participants)

155. Lavoie KL. Sex differences in the prevalence and impact of psychiatric disorders in COPD patients. Reseau en santé respiratoire du FRSQ – Regroupement stratégique en MPOC – Feb. 22, Montreal, Qc, 2008. (100 participants)

156. Lavoie KL. Motivational interviewing for lifestyle change in patients with chronic disease. Dept of Medicine, Hôpital du Sacré-Coeur de Montréal, February 7 & 21, Montreal, Qc, 2008. (Workshop). (25 participants)

157. Lavoie KL. Motivational interviewing for asthma adherence. Colloque Au bout de votre soufflé: L’asthme et ses leurres, observance et comorbidités psychiatriques. Médecine psychosomatique et Dépt de pneumologie, Hôpital du Sacré-Coeur de Montreal, Montreal, Quebec, January 19, 2007. (100 participants)

158. Lavoie KL. L’impact du stress sur l’asthme. Colloque Au bout de votre soufflé: L’asthme et ses leurres, observance et comorbidités psychiatriques. Médecine psychosomatique et Dépt de pneumologie, Hôpital du Sacré-Coeur de Montreal, Montreal, Quebec, January 19, 2007. (100 participants)

159. Lavoie KL. Motivational interviewing for health behavior change in asthmatics. Reseau Québécois de l’Asthme et de la MPOC (RQAM), Quebec City, Que, 25 novembre, 2006. (75 participants)

160. Lavoie KL. Asthma control and obesity : A behavioral perspective. Symposium on asthma and obesity. Réseau en santé respiratoire du FRSQ, Montreal, Que, 6 novembre, 2006. (75 participants)

Kim L. Lavoie Ph.D.

V June 2016

161. Lavoie KL. Motivational interviewing for treatment adherence. Astra-Zeneca Annual Meeting, Ste-Foy, Québec, August 23, 2006. (100 participants)

162. Lavoie KL. Motivational interviewing for smoking cessation. CLSC-Grand Littoral, Lévis, Quebec, 2 juin, 2006. (50 participants)

163. Lavoie KL. Behavioral interventions for health behavior change. Dept of Exercise Science, Concordia University, March 27, 2006. (25 participants)

164. Lavoie KL. Motivational interviewing to improve exercise adherence. Dept of Exercise Science, Concordia University, February 16, 2006. (40 participants)

165. Lavoie KL. Psychological approaches for stress reduction and behavior change. Dept of Exercise Science, Concordia University, March 27, 2006. (25 participants)

166. Lavoie KL. Motivational interviewing for health behavior change in asthmatics. Reseau Québécois de l’Asthme et de la MPOC (RQAM), Iles de Boucherville, Que, 25 novembre, 2005. (50 participants)

167. Lavoie KL. Psychological approaches for stress reduction and behavior change. Dept of Exercise Science, Concordia University, November 21, 2005. (50 participants)

168. Lavoie KL. La prévalence et impact du stress psychologique chez les patients sous évaluation pour l’asthme au travail. Institut de recherche en santé et sécurité au travail (IRSST), Montreal, Que, 11 novembre, 2005. (60 participants)

169. Lavoie KL. The psychological and behavioral determinants of chronic disease: Implications for asthma management. Clinical Epidemiology Grand Rounds, McGill University, Montreal, March 15, 2005. (25 participants)

170. Lavoie KL. The psychological and behavioral determinants of chronic disease: Implications for asthma management. Dept of Medicine, Hop. Sacre-Coeur de Mtl, June 1, 2005. (50 participants)

171. Lavoie KL. Living with asthma: challenges to achieving asthma control. Respiratory Medicine Leadership Institute, sponsored by Glaxosmithkline, Hotel Lowes, Montreal, April 9, 2005. (100 participants)

172. Lavoie KL. Anxiety, panic, and asthma. Workshop at the 32nd Conference de l’Ordre Professionnel des inhalotherapeutes du Quebec, Laval, Quebec, September 2004. (50 participants)

173. Lavoie KL. Anxiety, anxiety disorders, and poor asthma control. Association Pulmonaire du Quebec, Expert Round Table, Montreal, April 28, 2004. (30 participants)

174. Lavoie KL. Prevalence and impact of mood and anxiety disorders in asthmatics. Presented at the Annual Meeting of the Association des Pneumologues du Quebec, Quebec City, PQ; November 2003. (100 participants)

175. Lavoie KL. Anxiété patholoqique et troubles respiratoires. Colloqium : La conscience émotionnelle et la santé, Médicine psychosomatique de l’Hôpital du Sacre-Cœur de Montréal, May 10, 2002. (100 participants)

176. Lavoie KL. Anxiety sensitivity is associated with reduced heart rate variability in coronary artery disease patients. Presented at the Annual Meeting of the Anxiety Disorders Association of Quebec, Quebec City, PQ; May 2002. (250 participants)

CME PROGRAMS AND EDUCATIONAL MATERIALS (Steering committee & presenter) International: 1. PHYSACTO Trial: Case manager training in motivational (behavior-change) counselling for COPD patients.

Sponsored by Boehringer Ingelheim: Vienna 2014; Boston 2015; Montreal 2015. 2. Motivational interviewing for Vaccination Uptake. Merck Frosst Educational DVD, Montreal, QC., July, 2009. 3. Motivational interviewing for Hypertension Control. Merck Frosst Educational DVD, Montreal, QC., July, 2009. 4. Motivational interviewing for Asthma Control. Merck Frosst Educational DVD, Montreal, QC., July, 2009. 5. Motivational interviewing for Diabetes control. Merck Frosst Educational DVD, January 23, 2009. National: 6. “Changing the Conversation”- Adding the Art of Medicine to Asthma Management. National Training Program for

Family Physicians. Sponsored by Astra-Zeneca, 2016-2017. 7. Language of Change: Introduction to Motivational Communication to Optimize Outcomes in Patients with Chronic

Inflammatory Arthritis. National Training Program for Rheumatologists/Nurses. Sponsored by Janssen, 2015-2016.

Kim L. Lavoie Ph.D.

V June 2016

8. DERM-Connect Canada – Nurses Program: Motivational interviewing in the Dermatology Setting. Abbvie National Dermatology Program, 2014-2015.

9. DERM-Connect Canada – Physician Program: Motivational interviewing in the Dermatology Setting. Abbvie National Dermatology Program, 2014.

10. Motivational interviewing in the Rheumatology Setting. Abbvie National Nurses Program. September – October 2013. 11. ASPIRE: Motivational interviewing for Asthma. Takeda National General Practitioners Program. 2012-2013. 12. Heart and Stroke Foundation Hypertension Collaborative – Motivational Communication Training. Heart and Stroke

Foundation of Canada/Ontario, December 2010-2011. Provincial: 13. Lavoie KL, Bourbeau J. Motivational communication training videos (physical activity and adherence). Respiplus,

June 9, 2014. CONFERENCE ORGANIZATION/LEADERSHIP International: 1. iCEPS Congrès international sur la recherche interventionnelle non médicamenteuse, May 18-21, 2017, Montpellier,

FRANCE : Program co-chair 2. International Behavioral Trials Network (IBTN) Conference: May 19-21, Montreal, CANADA: Conference co-chair;

Scientific Committee co-chair; Organization Committee co-chair; Finance Committee co-chair. 3. iCEPS Congrès international sur la recherche interventionnelle non médicamenteuse, March 19-21, 2015, Montpellier,

FRANCE: Scientific Committee 4. International Behavioral Trials Network Meeting, April 20-23, 2014, Montreal, CANADA 5. American Psychosomatic Society Annual Meeting, March 12-15, 2011, San Antonio, TX: Program committee 6. American Psychosomatic Society Annual Meeting, March 10-13, 2010, Portland, OR: Program committee 7. American Psychosomatic Society Annual Meeting, March 4-7, 2009, Chicago, IL: Program committee

National: 8. Canadian Psychological Association Annual Meeting, Health Psychology and Behavioral Medicine Section, June 8-10,

2016, Victoria, BC: Program Track Chair 9. Canadian Psychological Association Annual Meeting, Health Psychology and Behavioral Medicine Section, June 4-6,

2015, Ottawa, ONT: Program Track Chair 10. Canadian Psychological Association Annual Meeting, Health Psychology and Behavioral Medicine Section, June 7-9, 2014

Vancouver, BC: Program Track Chair 11. Canadian Psychological Association Annual Meeting, Health Psychology and Behavioral Medicine Section, June 8-10,

2013, Quebec, QC: Program Track Chair CIHR-ICRS Young Investigators Leadership Forum, DATE, 2009, Steering Committee, Program Committee

12. CIHR-ICRS Young Investigators Leadership Forum, DATE, 2008, Toronto, ONT, Steering Committee, Program Committee 13. CIHR-ICRS Young Investigators Leadership Forum, DATE, 2007, Winnipeg, MB, Steering Committee, Program Committee 14. CIHR-ICRS Young Investigators Forum, DATE, 2006, Winnipeg, MB, Rising Stars Committee 15. CIHR-ICRS Young Investigators Forum, DATE, 2005, Winnipeg, MB, Rising Stars Committee J. PEER REVIEW COMMITTEES International 2015: Health Research Board of Ireland (Ireland) 2013: Agence Nationale de la Recherche (France)

Kim L. Lavoie Ph.D.

V June 2016

National/Provincial 2015-2016: Fonds de la recherche du Québec - Sante: Comite Chercheurs Boursiers Cliniciens J1/J2 2014-2015: Canadian Institutes of Health Research (CIHR): Health Services 2015: Fonds de la recherche du Québec – Santé: Research Center Evaluator 2013-2015: Canadian Institutes of Health Research (CIHR): Fellowships (Allied Health) 2009-2010: Canadian Institutes of Health Research (CIHR): Population Health 2009: Alberta Heritage Foundation for Medical Research (AHFMR) 2007-2010: Heart and Stroke Foundation of Canada (HSFC): Behavioural & Population Health LEADERSHIP ROLES:

• Co-Lead, Behavioral Sciences Platform, Canadian Respiratory Research Network (CRRN) 2015-pres • Chair, Canadian Network for Health Behavior Change (CAN-Change) 2014-pres • Co-Lead, International Behavioral Trials Network (IBTN) 2014-pres • Chair, Health Psychology and Behavioral Medicine Section, CDN Psychological Assoc. (CPA) 2013-pres • Member, KT Committee, CDN Assoc. of Cardiovascular Prevention and Rehabilitation 2013-pres • Member, Adherence Subcommittee, Canadian Hypertension Guideline Committee 2012-pres • Secretary, Health Psychology and Behavioral Medicine Section, CPA 2006-2013 • Executive Board Member, Association Pulmonaire/Lung Association of Quebec 2006-2011 • Member, Reg. Nurses Assoc. Ontario Best Practices Guideline – Chronic Disease 2007-2009 • Member, ICRH-CIHR New Frontiers Program Steering Committee 2007

MEMBERSHIPS Networks:

• Canadian Respiratory Research Network (CRRN) 2015-pres • International Behavioral Trials Network (IBTN) 2014-pres • Canadian Network for Health Behavior Change (CAN-Change) 2014-pres • GENESIS - Gender and Sex Determinants of Circulatory and Respiratory Health ICE Team 2009-pres • CIHR Respiratory Health Training Program 2009-pres • Reseau en santé respiratoire – FRSQ Respiratory Health Network 2007-pres

Societies/Associations:

• College of New Scholars, Artists and Scientists, Royal Society of Canada 2016-pres • Canadian Association of Cardiovascular Prevention and Rehabilitation (CACPR) 2012-pres • Canadian Thoracic Society (CTS)/American College of Chest Physicians (ACCP) 2012-pres • Canadian Psychological Association (CPA) 2006-pres • American Thoracic Society (ATS) 2003-pres • American Psychosomatic Society (APS) 1996-pres • Society of Behavioral Medicine (SBM) 1996-pres

EDITORIAL EXPERIENCE (manuscript reviewer) American Journal of Respiratory and Critical Care Medicine Annals of Behavioral Medicine Annals of Epidemiology British Medical Journal Biological Psychology BMC Pulmonary Medicine

Kim L. Lavoie Ph.D.

V June 2016

Canadian Journal of Cardiology Canadian Psychology Canadian Respiratory Journal CHEST Circulation Clinical and Experimental Allergy European Respiratory Journal JAMA Journal of Asthma Journal of Affective Disorders Journal of Behavioral Medicine Journal of Community Epidemiology Journal of Epidemiology and Community Health Journal of Psychosomatic Research Journal of Women’s Health Mayo Clinic Proceedings Medicine and Science in Sports and Exercise Medical Science Monitor Obesity Pediatrics Psychiatry Research Psychosomatic Medicine Psychosomatics Psychophysiology Respirology Respiratory Medicine Respiratory Research Sage Open Medical Case Reports Thorax TEACHING EXPERIENCE 2006-pres Behavioral Medicine Professor Psychology, UQAM PSY-9120 2005-2011 Seminare sectorielle: Professor Psychology, UQAM Anaylse du comportement PSY-7125 2003-2005 Adv. Behavior Disorders Invited lecturer Psychology, McGill University 1997-2000 Introduction to Psychology Teaching Assistant Psychology, Concordia University 2001 Behavior Therapy Invited lecturer Psychology, UQAM

Kim L. Lavoie Ph.D.

V June 2016

SUPERVISION - CURRENT STUDENTS: SUPERVISION RECORD: Postdoctoral Fellows Name Project Funding Affiliation Dates Current position Nicola Paine Safety of e-cigarettes CIHR/FRQS Concordia 2014-pres Postdoc Anthony Austin Acute stress and CVD MELS Concordia 2011-15 Asst. Prof, U Birmingham

(USA) Gregory Moullec Stress and COPD FRQS Concordia 2010-14 Asst. Prof, U of Montreal

(Canada)/FRQS J1 Catherine Laurin Stress and COPD FRQS Concordia 2011-14 Psychologist, & Research

Associate (Canada) Jet Velhuizen Van Zanten

Mental stress and ischemia

Wellcome Trust (UK)

Concordia 2008 Lecturer, U of Birmingham (UK)

Graduate Students Name Project Funding Affiliation Dates Current position Current PhD Students Vincent Gosselin Stress and physical activity JA DeSeve UQAM 2016- PhD student Avril Gagnon Stress and obesity JA DeSeve UQAM 2016- PhD student Cassandre Julien CBT for morbid obesity FRQS UQAM 2015- PhD student Anda Dragomir Physician training in MC FRQS UQAM 2015- PhD student Karine Ouellet Stress and asthma FRQS/CIHR UQAM 2010- PhD student Annik Plourde Depression and asthma CIHR/FRQS UQAM 2010- PhD student Ariane Jacob CBT for obese asthmatics FRQS/FRQSC UQAM 2009- PhD student Kevin Duckworth Rehab adherence in COPD MBMC U Sherbrooke 2009- PsyD student Steph Dumoulin Anxiety and virtual reality UQAM UQAM 2008- PhD student Current Master’s Students Emilie Dolan E-cigarettes and asthma JA DeSeve Concordia 2015- MSc student Candace Raddatz Acute stress and arrhythmia MBMC Concordia 2015- MSc student Adam Martinez Exercise and muscle

memory Concordia Concordia 2015- MSc student

Current Undergraduates (honours) Samantha Briand E-cigarette advertising NA Concordia 2016- BSc student Una White Asthma and obesity NA Concordia 2016 BSc student Graduated PhD Students Maxine Boudreau Panic disorder and asthma FRQS/CIHR UQAM 2008-15 Clinical Psychologist Philippe Stebenne Pain perception and

ischemia SSHRC UQAM 2008-15 Clinical Psychologist

Helene Favreau Panic disorder and asthma FRQS/IRSST UQAM 2008-14 Clinical Psychologist Marie-Jo Lessard Anxiety and chest pain MELS UQAM 2005-12 Postdoc (California) Maryann Joseph Stress and asthma SSHRC/FRQS McGill 2004-12 Clinical Psychologist Marie-Eve Pelland Anxiety and chest pain FRQS UQAM 2005-12 Clinical Psychologist Roxanne Pelletier Stress and CVD SSHRC/FRQS UQAM 2008-11 Postdoc (McGill) Graduated Master’s Students Alex Elhalwi Anxiety and inflammation FRQS Concordia 2012-14 Med student Anne Bouchard Stress and asthma/COPD FRQS UQAM 2006-09 Clinical Psychologist Alicia Wright Exercise and asthma CIHR Concordia 2012-14 Perform coordinator

Kim L. Lavoie Ph.D.

V June 2016

Helene Favreau Suicidal ideation and asthma FRQS/IRSST UQAM 2005-08 Clinical Psychologist Philippe Stebenne Stress and ischemia SSHRC UQAM 2005-08 Clinical Psychologist Roxanne Pelletier Stress and cardiac reactivity FRQS UQAM 2006-08 Perform coordinator Graduated Undergraduate Students G. Gour-Provencal Asthma adherence NA Concordia 2010-11 Med student Debbie Samek Self-efficacy and asthma NA McGill 2007-08 PhD student Isabelle Boisvert SES and asthma NA UQAM 2007-08 Psychologist Nadine Bekkouche Pain and ischemia NA McGill 2007-08 PhD student Isabelle Rousseau Exercise and asthma control NA UQAM 2006-07 Exercise physiologist Jennifer Gordon Behavior and endothelium NA McGill 2005-07 Assistant professor Roxanne Pelletier Depression and endothelium NA UQAM 2005-06 Postdoc/psychologist Silvana Barone FRQS McGill 2002-04 Pediatric fellow, John

Hopkins THESIS and PRD COMMITTEES 2015- Brahm Solomon (PhD, U Ottawa) – External Evaluator (thesis committee) 2014- Julie Maltais (PhD, UQAM) – Evaluator (PRD) 2012- Marie-Josee Lessard – PhD co-supervisor (evaluator, thesis committee) 2011- Marie-Eve Pelland – PhD co-supervisor (evaluator, thesis committee) Roxanne Pelletier – PhD supervisor (evaluator, thesis committee) 2010- Guillaume Foldes-Busque – Evaluator (thesis committee) Tina Landry (PhD, UQAM) – Evaluator (thesis committee) Emilie de Tournay (PhD, UQAM) – Evaluator (thesis committee) Maxine Boudreau (PhD-PRD, UQAM) - Evaluator 2009 - Karine Levesque (PhD, UQAM) – Evaluator (thesis committee) Marie-Claude Vinay (PhD, UQAM) – Evaluator (thesis committee) 2008 - Mélanie Jodoin (PhD, UQAM) – Evaluator (thesis committee) Anne Bouchard (PhD-PRD, UQAM) - Evaluator

Helene Favreau (PhD-PRD, UQAM) – Evaluator Philippe Stebenne (PhD-PRD, UQAM) – Evaluator Roxanne Pelletier (PhD-PRD, UQAM) - Evaluator 2007 - Sebastien Grenier (PhD, UQAM) – Evaluator (thesis committee) Lyne Marchand (PhD, UQAM) – Evaluator (thesis committee) Emmanuelle Roy (PhD, UQAM) – Evaluator (thesis committee) Marianne Roberge (PhD, UQAM) – Evaluator (thesis committee) Karine Levesque (PhD-PRD, UQAM) – Evaluator 2006 - Nancy Poirier (Psy-D PRD, UQAM) – Evaluator (thesis committee)

Stéphanie Goron (PhD-PRD, UQAM), - Evaluator Guy Racicot (PhD-PRD, UQAM) – Evaluator Dominique Lanctôt (PhD-PRD, UQAM) – Evaluator Isabelle Guay (PhD, UQAM) – Evaluator (thesis committee)

CLINICAL AND PROFESSIONAL TRAINING 2014 Workshop International Congress of Behavioral Medicine Behavioral Interventions: Full day workshop (7 hrs) Groningen, Netherlands (August 20, 2014) 2013 Workshop University College London (UCL) Behaviour change and complex interventions London, UK (July 29, 9:30-6pm)

Kim L. Lavoie Ph.D.

V June 2016

Symposium Universite de Laval Apprentissage et modifications comportementales:comment les favoriser Quebec City, QC (April 19, 2013)

Conference American Psychosomatic Society Health Psychology and Behavioural Medicine Miami, FL (March 2013) Conference Canadian Psychological Association Clinical Psychology Quebec City, QC (June 2013) 2012 Training workshop PsyMontreal Inc. Advanced Motivational Interviewing Montreal, QC (Dec 2012) Conference University College London (UCL) – London School of Hygiene and Tropical Medicine Social Science in Medicine London, UK (September 2012) Conference American Thoracic Society Chest Medicine and Clinical Respirology San Francisco, CA (May 2012) Conference Canadian Cardiovascular Congress Clinical cardiology Toronto, ON (October 2008) 2011 Conference American Psychosomatic Society Health Psychology and Behavioral Medicine San Antonio, CA (March 2011) U de Montpellier, Laboratoire Epsylon

Les réponses des sciences humaines aux enjeux de la santé Montpellier, FR (March 25, 2011)

Conference American College of Chest Physicians Chest Medicine and Clinical Cardiology Honolulu, HI (October 2011) 2010 Clinical Training University of Pittsburgh, NIH Mind-Body Center Behavioral Medicine Interventions Pittsburgh, PA (June 16-17, 2010) Conference American Psychosomatic Society Health Psychology and Behavioral Medicine Chicago, Il (March 2010) Conference Int. Society Respiratory Psychophysiology Respiratory Psychophysiology

Kim L. Lavoie Ph.D.

V June 2016

New York, NY (September 2010) Conference Canadian Cardiovascular Congress Clinical cardiology Montreal, QC (October 2010) 2009 Conference American Psychosomatic Society Health Psychology and Behavioral Medicine Portland, OR (March 2009) Conference Canadian Cardiovascular Congress Clinical cardiology Toronto, ON (October 2009) Conference Society of Behavioural Medicine Health Psychology and Behavioral Medicine Montreal, QC (April 2009) 2008 Conference Canadian Psychology Association Clinical Psychology Halifax, NS (June 2008) Conference Canadian Cardiovascular Congress Clinical cardiology Vancouver, BC (October 2008) 2007 Clinical training Robert Scales, PhD, Motivational-Interviewing Accredited Trainer (U New Mexico)

Motivational Interviewing 2-day Intensive Training Workshop Montreal, QC (September 2007)

Conference American Psychosomatic Society Health Psychology and Behavioral Medicine Prague, Czech Republic (March 2007) Conference Canadian Psychology Association Clinical Psychology Ottawa, ON (June 2007) Conference Canadian Cardiovascular Congress Clinical cardiology Quebec City, QC (October 2007)

2006 Conference American Psychosomatic Society Health Psychology and Behavioral Medicine Denver, CO (March 2006) Conference Canadian Cardiovascular Congress Clinical cardiology Vancouver, BC (October 2006)

2005 Conference American Psychosomatic Society

Kim L. Lavoie Ph.D.

V June 2016

Health Psychology and Behavioral Medicine Vancouver, BC (March 2005) Conference Canadian Cardiovascular Congress Clinical cardiology Montreal, QC (October 2005) Conference American College of Chest Physicians Chest Medicine and Clinical Cardiology Montreal, QC (October 2005) Conference American Thoracic Society Chest Medicine and Clinical Respirology San Diego, CA (May 2005) 2004 Clinical Research Training University of Pittsburgh, NIH Mind-Body Center Psychophysiology and health psychology Conference American Psychosomatic Society Health Psychology and Behavioral Medicine Orlando, FL (March 2004) Conference American Thoracic Society Chest Medicine and Clinical Respirology Orlando, CA (May 2004) 2003 Post-doctoral Training University of Pittsburgh, NIH Mind-Body Center Behavioral Medicine Interventions Post-doctoral Training Duke University, Dept. of Psychiatry Insomnia Interventions Conference American Psychosomatic Society Health Psychology and Behavioral Medicine Phoenix, AZ (March 2003) 2002-2003 Conference American Psychosomatic Society Health Psychology and Behavioral Medicine Barcelona, Spain (March 2002) 2000-2001 Internship Hopital du Sacre-Coeur, Montreal, PQ Psychosomatic Medicine Service Conference American Psychosomatic Society Health Psychology and Behavioral Medicine Monterey, CA (March 2001) Association of Cognitive & Behavior Therapy CBT and Clinical Psychology Philadelphia, PA (November 2000) 1999-2000 Internship Douglas Hospital, Montreal, PQ Cognitive-Behavioral Therapy Unit

Kim L. Lavoie Ph.D.

V June 2016

Conference Society of Behavioural Medicine Health Psychology and Behavioral Medicine San Diego, CA (March 2000) 1998-1999 Internship Hopital du Sacre-Coeur, Montreal, PQ Anxiety Disorders Clinic Conference American Psychosomatic Society Health Psychology and Behavioral Medicine Vancouver, BC (March 1999) 1997-1998 Internship Concordia University, Montreal, PQ Applied Psychology Center 1997 Internship Jewish General Hospital, Montreal, PQ Child Psychiatry Unit Internship Concordia University, Montreal, PQ Applied Psychology Center 1996-1997 Internship Concordia University, Montreal, PQ Applied Psychology Center 1995-1996 Internship Concordia University, Montreal, PQ Applied Psychology Center Internship Concordia University, Montreal, PQ Applied Psychology Center R. CLINICAL POSITIONS/CONSULTING 2016-pres Consultant Astra-Zeneca

- Motivational communication to improve asthma outcomes 2015-pres Consultant Janssen

- Motivational communication for Health Behavior Change in Rheumatology

2015-p Consultant Bayer

- Motivational communication for Health Behavior Change in Pulmonary Hypertension

2015 Consultant Mundi Pharma (Purdue)

- Motivational communication for Health Behavior Change in Asthma 2013-pres. Consultant Bohringer Ingelheim

- Behavour Modification in COPD 2012-pres. Consultant Kataka Medical Communication

- Motivational interviewing for Health Behavior Change

Kim L. Lavoie Ph.D.

V June 2016

Consultant Abbvie Pharmaceuticals - Motivational interviewing for Health Behavior Change in

Dermatology, Rheumatology

Consultant Takeda Pharmaceuticals - Motivational interviewing for Health Behavior change in Asthma

2009 Consultant Merck Pharmaceuticals

- Motivational interviewing for Health Behavior Change (hypertension, asthma, vaccination)

2006-pres. Consultant Heart and Stroke Foundation of Ontario

- Hypertension Initiative - Coping with Stress Handbook - Clinical Update Conference

2002-pres. Consultant Dept. De pneumologie, Hopital du Sacre-Coeur, Montreal, PQ

- Behavioral management of asthma 2002 Consultant Régie Régionale du Québec

- Behavioral management of asthma 1999-pres. Private practice Behavioural Medicine and Psychotherapy Clinic, 901 Gilford, Montreal